Risteys ·

OMOP concept ID	Test name	Measurement unit (harmonized unit)	N people	N records	Missing measurement value	Harmonized value distribution
3011412	b-cd3	10E9/l (e6/l)	1388	2857	0.60%
3011412	b-cd3	E6/l (e6/l)	1258	3892	0.00%
3011412	b-t-cd3	E9/l (e6/l)	749	1740	0.00%
3011412	b-t-cd3	— (—)	731	1231	100.00%	Distribution not available
3011412	b-t-cd3	E6/l (e6/l)	606	1174	0.00%
3011412	b-cd3	— (—)	172	202	100.00%	Distribution not available
3011412	b-t-cd3	E9/l______ (e6/l)	11	14	0.00%
3011412	b-cd3	10E9/l____ (e6/l)	8	10	0.00%	Distribution not available

LabWAS

N Cases

N Controls

-log₁₀(p)

cases

controls

cases

controls

unit

-log₁₀(p)

N cases

N controls

General symptoms and signs

1308

1778

3.73

323.31

2.6

2.2

1210.66

1207.72

e6/l

0.03

1134

1541

Malignant neoplasm, including Hilmo

1153

1770

3.85

315.36

3.1

2.3

1106.05

1274.98

e6/l

6.93

1012

1511

ILD medications: azathioprine

346

335

10.79

314.63

2.4

2.2

1054.61

1247.97

e6/l

2.40

294

289

Malignant neoplasm, wide definition

1146

1780

3.80

308.32

3.1

2.3

1104.56

1277.06

e6/l

7.18

1006

1517

Nonhereditary hypogammaglobulinemia

173

102.11

307.65

2.6

1.5

1208.72

1461.26

e6/l

0.68

149

Diffuse large B-cell lymphoma, including Hilmo

367

51.05

307.65

2.4

1.8

1011.31

1230.69

e6/l

1.38

331

ILD medications

2082

1700

6.75

307.65

2.7

2.3

1179.86

1261.41

e6/l

2.40

1789

1471

Liquid cancers, including Hilmo

1484

774

18.25

307.65

3.0

2.2

1174.69

1174.78

e6/l

0.00

1327

680

Fever of other and unknown origin

1281

1508

7.59

307.65

2.8

2.2

1238.91

1194.23

e6/l

0.23

1146

1307

Non-follicular lymphoma

655

263

29.61

307.65

2.7

2.1

1075.34

1113.34

e6/l

0.24

592

227

Pneumonia (excl. viral and due to other infectious organisms not elsewhere classified)

1560

2723

3.88

307.65

2.4

2.5

1252.64

1219.02

e6/l

0.20

1377

2334

Non-Hodgkin lymphoma, all, including Hilmo

905

256

41.53

307.65

2.8

2.0

1105.48

1087.55

e6/l

0.13

815

225

MS-disease / Multiple Sclerosis

468

224

24.30

307.65

3.7

2.1

1388.40

1332.65

e6/l

0.33

412

191

1447

1653

5.22

307.65

2.4

2.3

1185.42

1182.53

e6/l

0.03

1276

1425

Immunodeficiency with predominantly antibody defects

378

74.06

307.65

2.8

1.9

1328.97

1385.61

e6/l

0.14

325

Autoimmune diseases excluding thyroid diseases, strict definition

1538

2159

3.94

307.65

2.6

2.4

1180.05

1278.54

e6/l

1.13

1359

1852

Transplanted organ and tissue status

374

378

10.74

307.65

5.4

2.3

1054.76

1173.98

e6/l

1.21

331

317

Bacterial infection, other or unspecified, including avohilmo

1153

1628

5.97

307.65

2.8

2.3

1173.24

1185.87

e6/l

0.05

1040

1433

Malignant neoplasm

1151

1736

3.95

307.65

3.1

2.3

1091.30

1278.41

e6/l

8.29

1009

1478

Diseases of the blood and blood-forming organs and certain disorders involving the immune mechanism

2029

2254

6.23

307.65

2.7

2.3

1197.86

1248.76

e6/l

0.44

1769

1955

Secondary uncertain malignant neoplasm

565

258

23.95

307.65

2.6

2.0

1012.97

1104.88

e6/l

0.92

504

228

Diffuse large B-cell lymphoma

367

51.05

307.65

2.4

1.8

1011.31

1230.69

e6/l

1.38

331

Pneumonias (Asthma/COPD co-morbidities)

1644

2623

4.17

307.65

2.5

2.4

1241.81

1227.91

e6/l

0.08

1456

2244

Autoimmune diseases excluding thyroid diseases

1583

2229

3.91

307.65

2.5

2.4

1183.31

1277.50

e6/l

1.10

1397

1907

Agranulocytosis

454

396

12.55

307.65

3.2

2.3

1052.45

1190.02

e6/l

1.69

411

343

Primary_lymphoid and hematopoietic malignant neoplasms

1352

624

24.43

307.65

3.0

2.1

1128.58

1093.90

e6/l

0.37

1214

557

Anaemias

500

338

9.79

307.65

3.2

2.4

1129.57

1420.58

e6/l

5.95

430

281

Oral corticosteroids

1846

2093

5.28

307.65

2.3

2.5

1172.98

1226.39

e6/l

1.25

1609

1834

Inflammatory bowel disease treatment related agents

1888

2230

4.79

307.65

2.3

2.6

1174.95

1239.32

e6/l

1.68

1624

1946

Other bacterial diseases, including avohilmo

1561

2493

3.98

307.65

2.8

2.3

1157.55

1234.81

e6/l

2.09

1370

2149

Influenza and pneumonia

1680

2590

4.07

307.65

2.5

2.4

1196.73

1229.67

e6/l

0.61

1489

2213

COPD/asthma/ILD related pneumonia or pneumonia derived septicaemia

1447

1653

5.22

307.65

2.4

2.3

1185.42

1182.53

e6/l

0.03

1276

1425

Diffuse large B-cell lymphoma, helper endpoint

367

51.05

307.65

2.4

1.8

1011.31

1230.69

e6/l

1.38

331

ILD medications: immunosuppressive drugs

1589

1526

9.78

307.65

2.8

2.3

1118.63

1262.11

e6/l

4.94

1389

1330

Other diseases of blood and blood-forming organs, wide

747

815

9.79

307.65

3.0

2.4

1236.99

1180.21

e6/l

0.17

664

706

Other bacterial diseases

1565

2403

4.40

307.65

2.8

2.3

1209.94

1212.29

e6/l

0.01

1377

2074

Certain disorders involving the immune mechanism

762

728

11.36

307.65

3.0

2.4

1231.39

1181.51

e6/l

0.55

661

627

Rare circulating lymphoid malignancy, including Hilmo

217

41.33

307.65

4.4

2.8

1318.64

1368.46

e6/l

0.11

184

Explicit Sepsis

780

1529

4.76

307.65

3.0

2.4

1139.84

1191.53

e6/l

0.75

677

1346

Follicular lymphoma, hilmo

245

114

25.16

307.65

2.8

1.9

1050.47

1164.39

e6/l

0.50

223

100

Other septicaemia

683

1113

5.95

307.65

3.1

2.2

1122.00

1161.12

e6/l

0.46

593

978

Malignant neoplasm

1150

1734

3.95

307.65

3.1

2.3

1092.04

1275.96

e6/l

8.03

1008

1475

L04AX Other immunosuppressants

1090

2345

4.78

307.65

2.4

2.5

1102.49

1223.74

e6/l

3.30

946

2041

Septicaemia

758

1244

5.70

307.65

3.0

2.2

1140.70

1179.80

e6/l

0.49

659

1089

Abnormal findings on diagnostic imaging and in function studies, without diagnosis

1070

2277

4.18

307.65

2.4

1238.03

1146.38

e6/l

0.48

970

1995

Liquid cancers

1428

657

22.61

307.65

3.0

2.1

1182.43

1168.99

e6/l

0.06

1277

574

Demyelinating diseases of the central nervous system

492

286

19.61

307.65

3.7

2.0

1374.22

1312.24

e6/l

0.47

434

244

Non-Hodgkin lymphoma, all

310

57.83

307.65

3.1

1.8

1132.13

1128.04

e6/l

0.01

276

Other septicaemia, including avohilmo

702

1133

5.98

307.65

3.0

2.2

1258.47

1169.05

e6/l

0.27

609

996

Secondary and unspecified malignant neoplasm of lymph nodes

519

172

34.94

307.65

2.6

1.9

1025.91

1155.49

e6/l

1.11

464

148

All pneumoniae

1637

2677

4.05

307.65

2.4

2.5

1238.10

1233.29

e6/l

0.03

1450

2293

Abnormal findings on diagnostic imaging of lung

801

1618

4.80

307.65

2.4

2.3

1238.54

1109.14

e6/l

0.53

727

1451

Autoimmune diseases related-to ILD

1371

2818

4.14

307.65

2.7

2.3

1207.71

1235.86

e6/l

0.27

1212

2440

Explicit Sepsis, including avohilmo

797

1557

4.75

307.65

3.0

2.4

1258.89

1196.89

e6/l

0.20

692

1370

Enlarged lymph nodes

608

434

15.06

307.65

2.7

2.3

1107.45

1254.31

e6/l

2.45

539

384

Second line medication for Crohn's disease

1121

2407

4.78

307.65

2.4

2.5

1099.62

1228.09

e6/l

3.78

976

2098

First line medication for Crohn's disease

1845

1738

5.83

307.65

2.6

2.4

1183.96

1289.36

e6/l

3.29

1594

1497

Other and unspecified immunodeficiencies with predominantly antibody defects

206

104.70

307.65

3.2

1.4

1363.17

1524.70

e6/l

0.38

172

Secondary and unspecified malignant neoplasm of lymph nodes, including Hilmo

565

337

18.12

307.65

2.6

2.1

1014.62

1132.19

e6/l

1.48

505

298

Pneumonia, organism unspecified

1454

2415

4.21

307.65

2.4

2.5

1263.57

1211.58

e6/l

0.32

1285

2063

Kela reimbursement Agammaglobulinemia (D80-84)

173

120.91

307.65

3.6

1.3

1195.06

1567.74

e6/l

1.19

150

Immunodeficiencies

480

162

39.11

307.65

2.9

2.5

1357.37

1380.33

e6/l

0.08

411

135

L04AA Selective immunosuppressants

689

927

7.87

307.65

2.9

2.6

1136.34

1239.43

e6/l

1.65

595

796

Bacterial infection, other or unspecified

1110

1488

6.49

307.65

2.8

2.2

1175.62

1182.65

e6/l

0.03

1001

1319

ILD medications: prednisolone, methylprednisolone, prednisone

1885

1625

6.59

307.65

2.5

2.3

1188.67

1262.57

e6/l

1.88

1623

1412

ILD, hospital admission 2, with pulmonary infections

274

200

14.52

298.79

2.3

2.2

1014.09

1039.63

e6/l

0.16

249

175

Bacterial pneumonia (organism specified)

742

1513

4.54

291.65

2.3

2.5

1167.61

1157.71

e6/l

0.11

650

1334

Other demyelinating diseases of the central nervous system

214

103

23.94

289.71

3.7

2.1

1404.98

1332.26

e6/l

0.36

183

Aplastic and other anaemias

751

1597

4.40

284.68

2.7

2.3

1115.39

1171.03

e6/l

0.17

672

1410

Purpura and other haemorrhagic conditions

394

519

8.04

282.79

3.2

2.7

1011.22

1179.07

e6/l

2.43

342

455

Pneumocystosis

173

39.97

272.23

3.0

1.9

1039.75

1230.14

e6/l

0.46

167

Pneumocystosis, including avohilmo

173

39.97

272.23

3.0

1.9

1039.75

1230.14

e6/l

0.46

167

Certain infectious and parasitic diseases

1102

1503

3.72

271.34

2.7

2.2

1249.38

1208.19

e6/l

0.62

948

1298

Other degenerative diseases of the nervous system

544

667

6.12

270.97

3.6

2.1

1322.76

1097.96

e6/l

6.57

480

593

Viral infections characterized by skin and mucous membrane lesions

757

1876

4.13

270.85

2.6

1230.10

1212.01

e6/l

0.21

652

1618

GASTRO-related operations

888

1018

4.43

270.75

2.8

2.2

1240.07

1341.22

e6/l

1.95

763

818

Any gastric operation

888

1018

4.43

270.75

2.8

2.2

1240.07

1341.22

e6/l

1.95

763

818

Pneumonia due to other infectious organisms, not elsewhere classified

189

27.59

270.55

3.0

2.1

1025.76

1208.89

e6/l

1.43

179

Other and unspecified types of non-Hodgkin lymphoma, hilmo

212

118

20.50

268.85

2.8

2.0

1157.45

1179.88

e6/l

0.07

195

106

Bacterial Sepsis

731

1412

4.37

266.04

2.5

2.3

1144.53

1167.55

e6/l

0.22

641

1260

Drug-induced neutropenia

270

240

12.30

262.33

3.1

2.1

990.36

1161.43

e6/l

1.62

256

216

ILD, hospital admissions 3, with pneumonia sepsis

248

194

13.61

259.87

2.4

2.1

1021.53

1090.11

e6/l

0.45

227

166

Autoimmune diseases

1356

2247

3.10

258.21

2.5

2.4

1192.85

1279.30

e6/l

0.97

1190

1922

Other and unspecified anaemias

676

1476

4.40

258.07

2.7

2.2

1119.49

1171.58

e6/l

0.14

602

1305

Any reimbursement code in KELA

659

590

5.67

257.60

2.7

2.2

1277.19

1459.26

e6/l

3.57

553

488

Other anaemias

679

1486

4.37

257.22

2.7

2.2

1119.14

1171.94

e6/l

0.14

605

1312

COPD/asthma related infections

1137

1653

3.49

256.69

2.5

2.3

1248.86

1182.53

e6/l

1.20

993

1425

COPD/asthma/ILD related infections

1137

1653

3.49

256.69

2.5

2.3

1248.86

1182.53

e6/l

1.20

993

1425

Lymphoid leukaemia

241

186

14.40

256.31

3.7

2.2

1405.60

1190.75

e6/l

1.09

209

161

Infections, IBD-co-morbidities

339

231

10.67

253.43

3.3

2.3

1329.49

1147.76

e6/l

1.50

301

193

Azathioprine

346

451

8.00

249.88

2.4

2.7

1054.61

1235.82

e6/l

2.47

294

395

Asthma (only as main-diagnosis)

793

1032

4.35

248.59

1.9

2.4

1296.64

1197.50

e6/l

1.59

673

890

Thrombocytopenia, unspecified

264

246

11.65

248.21

3.4

2.3

1005.94

1209.38

e6/l

2.05

228

213

Asthma (only as main-diagnosis), excluding more controls

781

991

4.41

247.74

2.0

2.5

1296.00

1212.98

e6/l

1.17

662

853

Any event in cancer register

1129

2033

3.29

247.48

3.0

2.3

1108.58

1290.61

e6/l

7.82

985

1740

Protozoal diseases

186

23.44

247.47

3.0

2.1

1062.52

1254.61

e6/l

0.82

177

Respiratory diseases principally affecting the interstitium, IBD co-morbidites

284

150

13.90

244.36

2.3

1063.73

1182.14

e6/l

0.67

255

132

Protozoal diseases, including avohilmo

187

101

21.76

241.35

3.0

2.1

1067.79

1252.99

e6/l

0.84

178

Coagulation defects, purpura and other haemorrhagic conditions

452

812

5.80

239.97

3.1

2.5

1025.81

1208.48

e6/l

3.63

390

697

Asthma

827

1032

4.18

239.14

2.1

2.4

1292.35

1197.50

e6/l

1.45

704

890

Asthma, excluding more controls

810

991

4.25

238.00

2.1

2.5

1293.17

1212.98

e6/l

1.09

690

853

Dental caries

482

856

5.47

237.42

3.2

2.2

1179.03

1172.86

e6/l

0.05

405

753

Bacterial pneumoniae

593

1150

4.62

236.15

2.2

2.4

1218.64

1144.94

e6/l

1.15

507

993

Viral Sepsis

414

712

6.01

229.66

2.4

2.3

1168.43

1197.12

e6/l

0.22

359

630

Implicit bacterial Sepsis

613

1219

4.40

228.02

2.5

2.3

1122.29

1147.59

e6/l

0.22

543

1099

Implicit viral Sepsis

411

710

5.98

226.94

2.5

2.3

1163.71

1194.55

e6/l

0.24

356

629

Asthma (mode)

798

1043

4.07

224.92

2.1

2.4

1281.15

1198.87

e6/l

1.16

678

899

Used for control exclusion in common control thyroid runs

1229

2076

3.02

224.06

2.6

2.4

1185.86

1281.49

e6/l

1.02

1071

1779

Bacterial pneumonia, not elsewhere classified

547

1063

4.61

217.37

2.1

2.4

1218.51

1155.47

e6/l

0.85

462

921

L04AD Calcineurin inhibitors

334

498

7.14

214.98

3.7

2.7

1068.41

1274.81

e6/l

2.57

285

422

Implicit bacterial Sepsis, including avohilmo

645

1344

4.07

214.89

2.4

2.3

1123.70

1154.87

e6/l

0.30

569

1205

Chronic lymphocytic leukaemia

135

35.32

211.11

2.4

2.0

1308.34

1218.08

e6/l

0.23

124

Chronic lymphocytic leukaemia and small lyphocytis leukaemia, including Hilmo

135

35.32

211.11

2.4

2.0

1308.34

1218.08

e6/l

0.23

124

Chronic lymphocytic leukaemia, helper endpoint

135

35.32

211.11

2.4

2.0

1308.34

1218.08

e6/l

0.23

124

Caries of dentine

422

766

5.46

209.52

2.9

2.2

1155.56

1154.07

e6/l

0.01

366

671

Asthma, unspecified (mode), excluding more controls

576

937

4.46

205.42

2.1

2.5

1269.50

1211.56

e6/l

0.59

501

811

Viral infections characterized by skin and mucous membrane lesions, including avohilmo

1168

3364

2.74

204.75

2.5

2.4

1274.62

1213.54

e6/l

0.30

1007

2926

Bronchitis

1295

2925

2.68

203.84

2.6

2.3

1241.70

1212.00

e6/l

0.30

1119

2563

Asthma, unspecified (mode)

582

975

4.36

203.01

2.1

2.4

1268.00

1195.75

e6/l

0.82

507

846

Implicit viral Sepsis, including avohilmo

482

1065

4.62

199.90

2.4

2.3

1169.51

1202.67

e6/l

0.30

413

944

Oxycodone

577

1224

4.11

196.59

2.3

2.4

1149.55

1119.19

e6/l

0.29

521

1102

COPD differential diagnosis

778

1043

3.78

196.18

2.5

2.4

1238.20

1198.87

e6/l

0.41

679

899

ILD differential diagnosis

777

1043

3.77

195.58

2.5

2.4

1238.05

1198.87

e6/l

0.40

678

899

Systemic connective tissue disorders

549

1368

4.11

195.39

2.3

2.4

1117.00

1186.63

e6/l

0.99

492

1197

Other disorders of white blood cells

191

157

13.22

194.88

3.2

2.3

1688.43

1178.92

e6/l

0.46

164

143

Marginal zone B-cell lymphoma, including Hilmo

117

46.50

194.35

3.2

1.6

1228.50

1432.31

e6/l

0.45

109

Other pulmonary diagnosis

776

1048

3.75

193.79

2.5

2.4

1246.03

1202.36

e6/l

0.46

677

905

Excluding asthma or asthma-COPD overlap

774

1048

3.74

192.64

2.5

2.4

1238.39

1202.36

e6/l

0.36

676

905

Persons encountering health services for specific procedures and health care

1279

2912

2.62

191.33

2.4

2.5

1163.40

1285.81

e6/l

2.16

1117

2512

Other medical care

660

1548

3.64

189.16

2.2

2.6

1013.66

1242.22

e6/l

2.72

585

1362

Asthma-related pneumonia

574

1514

3.86

187.43

1.9

2.5

1268.15

1160.41

e6/l

1.83

487

1312

Other respiratory diseases principally affecting the interstitium

346

610

5.87

187.26

2.2

1030.50

1078.68

e6/l

0.44

312

546

Asthma, hospital admissions 3, pneumonia

574

1519

3.85

186.53

1.9

2.5

1268.15

1162.19

e6/l

1.78

487

1317

Asthma-related pneumonia or sepsis

574

1519

3.85

186.53

1.9

2.5

1268.15

1162.19

e6/l

1.78

487

1317

Asthma-related infections

822

2667

3.05

185.18

2.0

2.6

1309.49

1203.09

e6/l

1.43

697

2317

Asthma, hospital admission 2, infections

822

2667

3.05

185.18

2.0

2.6

1309.49

1203.09

e6/l

1.43

697

2317

Acute sinusitis

711

1952

3.36

185.06

2.7

2.3

1302.15

1189.79

e6/l

2.79

602

1708

Solid cancers

889

1666

3.16

184.59

2.6

2.2

1047.92

1266.92

e6/l

10.35

782

1423

Other interstitial pulmonary diseases

313

509

6.39

184.25

2.2

2.1

1020.75

1102.26

e6/l

0.80

284

451

1219

2310

2.70

184.18

2.5

2.3

1252.11

1198.70

e6/l

0.51

1062

2027

Optic neuritis

169

125

14.87

183.99

3.6

2.3

1314.24

1345.50

e6/l

0.11

144

115

Interstitial lung disease endpoints

313

512

6.36

183.17

2.2

2.1

1020.75

1103.68

e6/l

0.82

284

453

Interstitial lung disease

313

512

6.36

183.17

2.2

2.1

1020.75

1103.68

e6/l

0.82

284

453

ILD, hospital admissions

311

506

6.39

183.01

2.2

2.1

1020.61

1103.30

e6/l

0.81

282

448

Other and unspecified disorders of white blood cells

159

110

15.94

179.78

3.5

2.4

1782.52

1170.32

e6/l

0.47

139

Non-invasive ventilation

409

730

4.95

175.46

2.4

2.7

1208.88

1171.94

e6/l

0.34

376

637

Solid cancers, including Hilmo

897

1734

3.05

175.06

2.6

2.3

1073.94

1273.59

e6/l

8.62

790

1479

Zoster [herpes zoster]

344

643

5.52

174.71

2.8

2.3

1178.24

1138.55

e6/l

0.32

301

570

Acute upper respiratory infections of multiple and unspecified sites

935

2427

2.84

173.30

2.8

2.2

1241.86

1176.58

e6/l

1.39

806

2125

Neoplasms

874

1473

3.15

173.09

3.0

2.3

1185.21

1367.40

e6/l

6.09

729

1245

Implicit fungal Sepsis

148

16.51

171.13

2.4

2.0

1102.61

1083.48

e6/l

0.08

128

Fungal Sepsis

154

112

14.96

169.01

2.4

2.1

1137.50

1077.28

e6/l

0.30

134

100

Hodgkin lymphoma, hilmo

132

18.80

161.35

2.5

2.4

963.11

1350.20

e6/l

1.76

123

Provisional assignment of new diseases of uncertain etiology

710

2346

3.05

160.38

2.3

2.4

1226.51

1202.16

e6/l

0.27

607

2041

Codes for special purposes

710

2352

3.04

159.63

2.3

2.4

1226.51

1203.22

e6/l

0.26

607

2044

Use of glatiramer acetate

113

27.13

158.91

4.1

2.6

1296.87

1268.07

e6/l

0.10

100

Covid-19 confirmed case

535

1521

3.58

156.97

2.3

2.4

1251.47

1185.97

e6/l

0.78

465

1330

Cytomegalovirus infection, IBD co-morbidity

130

18.64

156.43

4.5

2.1

1404.30

1115.39

e6/l

1.45

117

All influenza

383

860

4.55

156.22

2.8

2.6

1256.42

1188.70

e6/l

0.69

339

727

Implicit Sepsis

856

2269

2.81

155.95

2.3

2.4

1134.17

1238.55

e6/l

1.17

754

1997

Cytomegaloviral disease

130

18.29

155.32

4.5

2.0

1404.30

1183.59

e6/l

0.89

117

Headache

674

1654

3.18

154.35

2.5

2.2

1380.09

1212.24

e6/l

4.75

587

1430

Bronchiectasis

200

242

8.73

154.25

2.0

1245.35

1108.65

e6/l

1.17

167

213

Cytomegaloviral disease, including avohilmo

131

17.75

154.22

4.5

2.0

1398.92

1235.15

e6/l

0.56

118

Implicit fungal Sepsis, including avohilmo

179

190

9.93

152.75

2.3

2.4

1135.37

1134.24

e6/l

0.01

152

172

Multiple myeloma, including Hilmo

118

19.95

151.08

2.9

1.7

1046.25

1172.05

e6/l

0.50

106

Disorders of optic nerve and visual pathways

242

373

6.82

150.65

3.4

2.3

1359.73

1301.75

e6/l

0.36

205

317

641

2080

3.11

149.77

1.9

2.7

1345.23

1211.67

e6/l

3.25

538

1782

ILD, hospital admissions 1, main diag only

268

465

5.99

147.77

2.2

2.1

1015.98

1121.31

e6/l

1.05

241

411

Other acute lower respiratory infections

705

2323

2.93

147.52

2.5

1288.79

1181.86

e6/l

2.43

622

1985

Reimbursement for rheumatic diseases

707

2457

2.90

146.55

2.0

2.5

1076.24

1245.87

e6/l

2.71

631

2140

Undetermined asthma

205

271

7.76

145.72

2.0

2.4

1378.43

1147.89

e6/l

2.75

173

228

Use of interferon beta-1a

117

19.36

144.32

3.8

2.5

1202.10

1315.68

e6/l

0.47

101

Viral pneumonia

243

392

6.41

144.07

2.5

2.6

1030.89

1177.77

e6/l

1.73

213

316

Undetermined asthma, excluding more controls

205

275

7.65

143.88

2.0

2.4

1378.43

1148.16

e6/l

2.76

173

231

Acute upper respiratory infections

1104

2743

2.43

143.46

2.5

2.3

1256.72

1199.11

e6/l

0.67

947

2411

Common variable immunodeficiency

57.89

143.22

2.4

1.3

1135.19

1457.89

e6/l

0.68

Selective deficiency of immunoglobulin G [IgG] subclasses

56.13

141.99

2.2

1.9

1353.39

1382.24

e6/l

0.04

Zoster [herpes zoster], including avohilmo

621

1984

3.06

141.02

2.6

2.3

1268.25

1159.91

e6/l

0.30

548

1756

Herpesviral [herpes simplex] infections

252

438

5.98

138.77

2.5

1279.33

1242.48

e6/l

0.23

215

384

Other/unspecified cytomegaloviral diseases

114

18.49

136.33

4.8

2.0

1410.33

1175.28

e6/l

0.88

103

General examination and investigation of persons without complaint and reported diagnosis

655

1070

3.21

133.63

3.0

2.1

1234.03

1119.77

e6/l

2.00

577

945

Other immunodeficiencies

30.58

133.47

2.8

1.7

1466.72

1443.93

e6/l

0.04

Chronic sinusitis

552

1772

3.16

133.14

2.2

2.5

1333.64

1113.64

e6/l

7.12

451

1561

Diagnoses used for exclusion with ILD

379

958

4.05

132.48

2.3

2.4

940.61

1184.91

e6/l

6.75

350

852

Malaise and fatigue

517

1214

3.39

131.71

2.2

1228.32

1191.82

e6/l

0.35

447

1057

Mycoses

428

1193

3.67

130.00

2.5

1184.88

1197.90

e6/l

0.11

368

1044

Implicit Sepsis, including avohilmo

868

2486

2.52

127.07

2.3

2.4

1119.62

1243.78

e6/l

1.77

762

2181

Symptoms and signs involving the skin and subcutaneous tissue

834

3198

2.49

126.90

2.7

2.3

1224.40

1212.31

e6/l

0.11

718

2805

Polyarthropathies

800

1956

2.66

126.35

2.2

2.6

1124.93

1181.40

e6/l

0.84

714

1707

Failure and rejection of transplanted organs and tissues

21.17

124.55

8.6

2.3

929.38

1165.17

e6/l

1.02

Asthma and opportunity respiratory infection

137

134

10.97

124.45

1.7

2.1

1377.19

1082.78

e6/l

2.53

107

116

Medical observation and evaluation for suspected diseases and conditions

642

1070

3.10

123.17

3.0

2.1

1282.79

1119.77

e6/l

3.22

551

945

Other special examinations and investigations of persons without complaint or reported diagnosis

645

1070

3.08

122.50

2.5

2.1

1272.00

1119.77

e6/l

2.91

556

945

Human immunodeficiency virus [HIV] disease

104

17.70

122.01

5.3

2.4

1580.37

1379.62

e6/l

0.62

Other disorders involving the immune mechanism, not elsewhere classified

121

102

13.02

121.76

5.5

2.2

1315.64

1266.29

e6/l

0.15

Persons with potential health hazards related to family and personal history and certain conditions influencing health status

1072

3011

2.27

121.22

3.2

2.2

1178.48

1263.62

e6/l

1.17

932

2598

Human immunodeficiency virus [HIV] disease, including avohilmo

104

17.14

120.12

5.3

2.4

1580.37

1381.45

e6/l

0.63

Certain infectious and parasitic diseases, including avohilmo

643

1064

3.05

119.93

2.7

2.1

1216.31

1181.59

e6/l

0.36

551

917

Other diseases of pleura

528

1509

3.09

118.32

2.3

2.4

1024.57

1139.04

e6/l

2.13

467

1347

Other and unspecified disorders involving the immune mechanism, not elsewhere classified

116

13.30

118.14

5.7

2.2

1328.90

1238.33

e6/l

0.30

Other and unspecified dermatitis

638

2373

2.72

117.93

2.5

2.4

1242.09

1205.66

e6/l

0.27

544

2074

Mature T/NK-cell lymphomas, hilmo

25.34

116.48

3.4

1.9

1392.35

1146.12

e6/l

0.50

Other systemic involvement of connective tissue (FG)

341

858

3.97

116.18

2.3

2.4

1162.34

1222.09

e6/l

0.55

302

758

Dermatitis

721

2801

2.55

115.94

2.5

2.4

1222.82

1198.13

e6/l

0.20

619

2454

Acute bronchitis

526

1750

2.99

115.08

2.5

2.6

1300.36

1189.90

e6/l

2.00

468

1490

Acute myeloid leukaemia and myelodysplastic syndromes

28.19

114.04

6.0

2.3

999.04

1386.76

e6/l

1.07

Sarcoidosis

234

457

5.29

113.43

2.4

905.67

1152.12

e6/l

4.20

215

400

Renal tubulo-interstitial diseases

926

3018

2.27

108.55

2.5

2.4

1156.76

1229.44

e6/l

0.86

823

2622

Explicit bacterial Sepsis

188

312

6.22

108.39

2.6

2.4

1216.99

1152.71

e6/l

0.37

163

278

Asthma (diagnoses ohter than nonallergic)

947

3481

2.22

107.41

2.0

2.5

1288.95

1212.88

e6/l

1.12

799

3046

Explicit bacterial Sepsis, including avohilmo

189

319

6.11

107.10

2.6

2.4

1215.24

1151.08

e6/l

0.37

164

282

Abnormalities of breathing

930

2320

2.31

107.01

2.2

2.5

1261.93

1205.99

e6/l

0.95

804

2000

Herpesviral [herpes simplex] infections, including avohilmo

362

1031

3.58

106.47

2.4

2.6

1307.47

1243.72

e6/l

0.70

303

892

Streptococcal septicaemia

156

217

7.43

106.45

2.8

2.5

1219.26

1141.45

e6/l

0.41

136

190

Renal failure

535

1601

2.88

106.19

2.5

2.3

1073.58

1126.28

e6/l

0.63

489

1415

Condition for Implicit Sepsis (Organ dysfunction codes)

854

2550

2.34

106.17

2.3

2.4

1131.60

1251.30

e6/l

1.68

748

2235

Oedema, not elsewhere classified

328

856

3.79

105.01

2.3

2.2

1154.07

1163.80

e6/l

0.07

279

761

Streptococcal septicaemia, including avohilmo

157

226

7.18

103.86

2.7

2.4

1217.15

1149.28

e6/l

0.35

137

197

Osteopathies and chondropathies

635

2275

2.58

103.59

2.5

1203.71

1204.00

e6/l

0.00

564

1990

All kidney diseases

1023

3210

2.15

103.53

2.5

2.4

1173.15

1250.10

e6/l

1.06

899

2778

Neurological diseases

859

1825

2.38

101.62

2.8

2.3

1331.60

1176.19

e6/l

4.24

734

1556

Cough

489

1591

2.91

100.66

2.7

2.6

1191.60

1163.47

e6/l

0.29

421

1366

Other systemic involvement of connective tissue

359

1056

3.46

100.46

2.3

1153.33

1198.96

e6/l

0.40

319

926

Multiple myeloma and malignant plasma cell neoplasms

123

139

9.39

100.33

2.9

1.9

1065.86

1103.30

e6/l

0.13

111

124

Dyspnoea

929

3082

2.19

100.33

2.1

2.5

1204.34

1215.77

e6/l

0.09

818

2689

Other viral diseases

435

1440

3.07

99.47

3.5

2.6

1305.92

1292.09

e6/l

0.10

372

1198

All chronic kidney diseases

614

1909

2.59

98.13

2.4

2.5

1117.37

1160.30

e6/l

0.53

553

1656

Malignant neoplasm of eye, brain and central nervous system

104

11.41

97.99

2.0

2.5

1080.59

1333.01

e6/l

1.32

Diseases of the respiratory system

538

910

2.99

97.05

2.3

1248.82

1192.42

e6/l

0.53

460

787

Condition for Implicit Sepsis (Organ dysfunction codes), including avohilmo

879

2691

2.22

96.47

2.3

2.4

1161.28

1258.55

e6/l

1.19

760

2347

Other viral diseases, including avohilmo

510

1876

2.73

94.58

3.2

2.5

1310.13

1268.25

e6/l

0.42

433

1581

SLE (Finngen)

13.92

93.66

2.6

3.3

882.77

1236.66

e6/l

1.39

Intestinal infectious diseases

977

3512

2.08

93.39

2.5

2.4

1257.24

1218.74

e6/l

0.43

842

3056

Complications of medical and surgical care

760

3052

2.26

92.26

2.9

2.2

1200.44

1204.18

e6/l

0.03

673

2683

Osteoporosis

317

825

3.59

91.87

2.5

2.2

1053.54

1260.20

e6/l

0.95

283

731

Malignant neoplasm of eye, brain and central nervous system, including Hilmo

125

160

8.10

91.75

2.2

1049.79

1300.89

e6/l

2.00

113

139

Malignant neoplasm of brain

12.70

91.60

1.9

2.3

1029.75

1421.07

e6/l

2.28

Asthma, hospital admissions , main diagnosis only

854

3487

2.15

91.12

1.9

2.5

1309.56

1209.95

e6/l

1.66

726

3036

Enterocolitis due to Clostridium difficile

180

343

5.41

89.71

2.8

2.3

1200.33

1133.95

e6/l

0.38

162

309

Monoclonal gammopathy of undetermined significance (MGUS), including Hilmo

12.55

89.58

2.5

2.1

1351.00

1164.76

e6/l

0.60

Chronic kidney disease

360

1091

3.22

89.23

2.5

2.3

1079.31

1134.26

e6/l

0.48

330

962

Chronic lower respiratory diseases

1180

3179

1.97

88.96

2.1

2.6

1282.11

1216.75

e6/l

0.88

1007

2774

Dermatitis and eczema

1105

3307

1.99

88.79

2.5

2.4

1266.29

1208.49

e6/l

0.70

955

2892

Methotrexate

179

343

5.33

88.46

1.9

2.7

1163.30

1187.99

e6/l

0.11

161

306

Persons encountering health services for other counselling and medical advice, not elsewhere classified

1070

2815

2.03

88.45

2.4

2.5

1200.91

1211.88

e6/l

0.09

940

2437

Symptoms, signs and abnormal clinical and laboratory findings, not elsewhere classified

297

350

4.29

88.21

2.8

2.0

1300.71

1292.87

e6/l

0.04

254

295

Other or unspecified immunodeficiency

50.02

87.12

3.2

1.4

1388.24

1480.42

e6/l

0.13

Candidiasis, including avohilmo

387

1298

3.03

87.10

2.4

1325.19

1224.26

e6/l

1.17

325

1132

Multiple myeloma, Monoclonal gammopathy of undetermined significance (MGUS)

19.50

86.16

2.7

2.2

1012.05

1224.87

e6/l

0.58

Multiple myeloma

19.50

86.16

2.7

2.2

1012.05

1224.87

e6/l

0.58

Other necrotizing vasculopathies (FG)

121

161

7.84

86.10

2.4

2.1

1131.39

1087.64

e6/l

0.20

112

143

Pain, not elsewhere classified

288

811

3.60

86.05

2.2

2.3

1348.32

1248.51

e6/l

0.93

247

708

Malignant neoplasm of brain, including Hilmo

104

115

9.46

86.02

2.0

2.5

1023.24

1344.02

e6/l

2.37

103

Symptoms and signs involving the nervous and musculoskeletal systems

629

2706

2.35

85.43

2.9

2.4

1348.94

1194.83

e6/l

2.25

565

2343

Diseases of the skin and subcutaneous tissue

907

2130

2.15

85.24

2.6

2.4

1250.79

1223.03

e6/l

0.20

778

1870

Complications of surgical and medical care, not elsewhere classified

971

3213

2.03

84.66

2.8

2.3

1189.08

1218.47

e6/l

0.29

863

2802

Acute renal failure

277

770

3.66

84.62

2.5

2.2

1002.80

1101.17

e6/l

1.08

259

681

Candidiasis

231

569

4.17

84.02

2.3

2.4

1246.31

1208.34

e6/l

0.23

198

494

Heart failure, not strict

729

2182

2.27

83.73

2.3

2.5

1058.92

1207.55

e6/l

2.01

648

1935

Other necrotizing vasculopathies

136

212

6.68

83.72

2.4

2.0

1100.89

1148.76

e6/l

0.21

122

191

Idiopathic thrombocytopenic purpura

11.36

82.88

3.0

2.2

1156.18

1315.46

e6/l

0.42

Human immunodeficiency virus [HIV] disease resulting in other conditions

14.12

82.59

4.9

2.3

1567.37

1438.14

e6/l

0.32

Opioids

890

2173

2.13

82.28

2.4

1288.77

1191.56

e6/l

2.16

768

1895

Any death

627

1853

2.39

82.06

2.2

2.4

1118.39

1151.37

e6/l

0.08

567

1657

Other disorders of lacrimal gland

429

1572

2.77

81.98

3.0

2.3

1194.69

1163.19

e6/l

0.33

389

1368

Finngen Rheumatological endpoints

920

2533

2.08

81.80

2.3

2.6

1197.03

1243.42

e6/l

0.74

803

2191

Human immunodeficiency virus [HIV] disease resulting in other conditions, including avohilmo

13.89

81.80

4.9

2.3

1567.37

1449.05

e6/l

0.29

Other bacterial intestinal infections

245

647

3.86

80.74

2.8

2.5

1216.47

1145.14

e6/l

0.53

219

572

Other reaction to severe stress, and adjustment disorders

443

1666

2.69

80.28

3.1

2.4

1304.52

1234.29

e6/l

1.01

401

1430

Diarrhoea and gastroenteritis of presumed infectious origin

732

3045

2.16

80.13

2.5

2.4

1259.77

1195.33

e6/l

1.06

627

2632

Other and unspecified aplastic anaemias

24.20

80.10

2.3

1.8

1008.57

1139.91

e6/l

0.29

Other symptoms and signs involving the nervous and musculoskeletal systems

480

1886

2.58

79.71

3.1

2.5

1335.82

1187.32

e6/l

3.10

437

1632

Tramadol

718

1933

2.25

79.03

2.2

2.4

1280.08

1174.16

e6/l

1.97

629

1703

Adrenocortical insufficiency

100

118

9.02

78.94

1.8

2.3

1343.11

1247.12

e6/l

0.33

100

Infections of the skin and subcutaneous tissue

649

2880

2.24

78.62

2.5

1215.50

1207.56

e6/l

0.08

557

2487

Persons encountering health services in other circumstances, wide

1063

2817

1.95

77.99

2.5

1180.31

1211.98

e6/l

0.31

942

2438

Systemic lupus erythematosus

10.23

76.69

2.6

2.5

882.77

1223.82

e6/l

1.85

Other encephalitis

10.99

76.46

3.0

2.1

1267.81

1133.69

e6/l

0.57

Rheumatoid arthritis

354

1058

3.00

76.45

2.0

2.4

1010.54

1151.10

e6/l

2.31

315

938

Inflammatory diseases of the central nervous system

159

314

5.25

76.34

2.5

2.4

1299.01

1228.51

e6/l

0.40

135

270

Erysipelas, including avohilmo

591

1873

2.35

76.18

2.1

2.3

1182.71

1161.12

e6/l

0.19

514

1645

Bacterial intestinal infections, IBD co-morbidities

243

666

3.72

75.91

2.8

2.4

1218.75

1100.88

e6/l

1.09

217

585

Erysipelas

462

1547

2.60

75.84

2.1

2.2

1177.50

1160.36

e6/l

0.12

404

1380

Encephalitis

10.45

75.67

3.0

2.1

1283.05

1093.44

e6/l

0.95

Seropositive rheumatoid arthritis

277

823

3.40

75.59

2.0

2.4

979.14

1212.81

e6/l

5.12

247

735

Examination and observation for other reasons

497

1068

2.65

75.58

2.5

2.1

1357.10

1119.68

e6/l

4.51

402

943

Care involving use of rehabilitation procedures

613

2451

2.27

75.46

2.3

2.6

1244.19

1264.07

e6/l

0.14

517

2119

Malignant neoplasm of respiratory system and intrathoracic organs, including Hilmo

197

368

4.46

74.44

2.1

1.9

974.99

1072.05

e6/l

0.89

181

325

Allergic asthma (mode)

220

556

3.91

73.80

1.9

2.5

1363.75

1183.55

e6/l

2.37

175

458

Nausea and vomiting

323

1050

3.04

73.05

2.7

2.5

1254.07

1219.40

e6/l

0.25

277

901

Dialysis, with operation codes

197

479

4.23

73.04

2.6

1024.06

1176.08

e6/l

1.22

171

413

Allergic asthma (mode), excluding more controls

220

562

3.86

72.69

1.9

2.5

1363.75

1198.82

e6/l

2.05

175

465

Disorders of other endocrine glands

501

2068

2.41

72.10

2.7

2.5

1232.14

1238.57

e6/l

0.05

438

1772

Disorders of lacrimal system

475

1914

2.47

71.98

2.9

2.3

1190.91

1212.18

e6/l

0.13

428

1665

Visual disturbances and blindness

552

2425

2.30

71.41

2.5

2.4

1290.63

1214.49

e6/l

0.75

478

2111

Neurological diseases, wide definition

298

419

3.61

71.36

3.1

2.1

1385.39

1323.14

e6/l

0.37

246

319

Nutritional anaemias

503

2028

2.39

70.51

2.6

2.4

1076.60

1174.23

e6/l

1.93

445

1783

Gastrointestinal diseases

544

1109

2.48

70.09

2.6

2.4

1295.22

1230.60

e6/l

0.69

456

953

Hernia of abdominal wall, postoperative

157

326

4.84

69.85

2.2

2.1

1951.14

1218.12

e6/l

0.63

141

274

Other malignant neoplasms of skin (=non-melanoma skin cancer), including Hilmo

343

776

3.01

69.37

2.1

2.0

1123.51

1122.61

e6/l

0.01

306

685

Other malignant neoplasms of skin (=non-melanoma skin cancer)

333

746

3.06

69.28

2.1

2.0

1109.81

1117.84

e6/l

0.06

295

657

Sulfasalazine

260

792

3.32

68.83

2.1

2.7

1129.35

1231.95

e6/l

0.88

228

707

Other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

163

361

4.65

68.24

5.7

2.2

1080.65

1186.14

e6/l

0.82

147

325

Viral pneumonia (known virus, not influenza)

9.83

68.21

3.0

2.8

1141.01

1249.72

e6/l

0.36

Cardiovascular diseases (excluding rheumatic etc)

663

1741

2.20

68.08

2.4

2.8

1255.21

1324.98

e6/l

1.03

560

1465

Nephropathy related operations

192

486

4.06

67.47

2.6

2.5

1047.89

1172.49

e6/l

0.88

167

419

Iron deficiency anaemia

444

1788

2.46

66.94

2.5

2.4

1082.80

1185.04

e6/l

1.81

392

1557

Other specified/unspecified systemic involvement of connective tissue

107

166

6.70

66.23

2.0

2.8

1113.19

1183.04

e6/l

0.29

147

Malignant neoplasm of skin

355

849

2.85

65.62

2.2

2.1

1108.44

1139.74

e6/l

0.29

315

749

Chorioretinal inflammation

9.56

65.25

2.3

2.2

1200.66

1372.50

e6/l

0.58

SLE, strict definition

9.03

65.08

2.6

2.5

890.13

1192.55

e6/l

2.33

SLE, ICD10

9.03

65.08

2.6

2.5

890.13

1192.55

e6/l

2.33

Parasetamol

640

1469

2.22

65.03

2.6

2.4

1243.92

1182.45

e6/l

0.87

542

1266

Visual disturbances

512

2273

2.28

64.88

2.5

2.4

1294.40

1174.91

e6/l

2.37

440

1981

Symptoms and signs involving the circulatory and respiratory systems

897

2326

1.94

64.82

2.5

1280.32

1206.11

e6/l

1.43

781

2006

Cardiovascular diseases

627

1513

2.22

64.52

2.5

2.8

1296.53

1338.44

e6/l

0.46

528

1277

Diseases of oesophagus, stomach and duodenum

973

3106

1.86

64.33

2.2

2.5

1222.87

1221.71

e6/l

0.01

846

2706

Gout, FINNGEN

285

952

3.01

63.83

2.4

2.2

1057.60

1058.41

e6/l

0.00

256

862

Rheumatoid arthritis, including avohilmo

386

1523

2.57

63.72

2.0

2.3

1023.13

1201.55

e6/l

3.67

341

1344

Other heart diseases

498

1375

2.38

63.38

2.4

2.9

1087.40

1285.99

e6/l

5.56

434

1164

Malignant neoplasm of skin, including Hilmo

370

912

2.74

63.33

2.1

1106.33

1150.05

e6/l

0.46

330

807

Persons encountering health services for examination and investigation

513

1070

2.42

63.18

2.6

2.1

1221.79

1119.77

e6/l

1.33

434

945

Abnormal findings on diagnostic imaging of central nervous system

100

152

6.85

63.15

2.8

1363.73

1325.48

e6/l

0.11

130

Respiratory disorders in diseases classified elsewhere

15.97

63.09

2.3

1.9

1085.08

1172.53

e6/l

0.21

ILD-related respiratory insufficiency

9.16

62.61

2.1

2.0

911.64

1243.33

e6/l

1.34

Other diseases of the respiratory system

240

740

3.30

62.52

2.3

2.5

1092.16

1100.26

e6/l

0.04

204

656

Other respiratory disorders and diseases

240

740

3.30

62.52

2.3

2.5

1092.16

1100.26

e6/l

0.04

204

656

Codeine

783

2130

2.00

62.41

2.3

2.4

1305.16

1187.71

e6/l

2.77

674

1861

Diseases of the eye and adnexa

737

1808

2.06

62.04

2.9

2.4

1308.83

1205.84

e6/l

1.93

632

1558

Surgical and other medical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

573

2657

2.13

61.66

3.2

2.2

1175.06

1182.49

e6/l

0.05

509

2334

Acquired haemolytic anaemia

11.37

61.62

3.1

1.8

1066.84

1116.28

e6/l

0.13

Respiratory insufficiency

130

7.20

61.59

1.9

2.3

1154.68

1017.28

e6/l

0.63

115

Gout

285

825

3.00

61.28

2.4

1057.60

1098.31

e6/l

0.27

256

750

Other diseases of intestines

987

3032

1.82

60.54

2.4

2.5

1246.04

1218.23

e6/l

0.40

837

2635

Noninfective enteritis and colitis

498

2250

2.23

60.30

2.4

2.6

1237.07

1215.38

e6/l

0.21

441

1922

Malignant neoplasm of respiratory system and intrathoracic organs

165

324

4.27

59.45

1.9

946.43

1052.82

e6/l

1.02

155

285

Early onset COPD, excluding more controls

161

391

4.16

59.42

1.8

2.4

1328.16

1055.49

e6/l

2.93

140

352

Other disorders of adrenal gland

104

176

6.19

59.25

1.8

2.4

1341.68

1342.39

e6/l

0.00

147

Other bacterial intestinal infections, including avohilmo

272

931

2.97

59.24

2.8

2.4

1225.15

1181.46

e6/l

0.31

242

819

Drug-induced adrenocortical insufficiency

10.48

59.24

1.6

2.2

1361.71

1239.86

e6/l

0.31

Venous thromboembolism

489

2125

2.24

59.08

2.2

2.3

1305.90

1148.06

e6/l

0.37

441

1890

Non-allergic asthma (mode), excluding more controls

165

407

4.07

58.84

1.6

2.3

1221.11

1139.83

e6/l

0.54

137

337

Acute lymphocytic leukaemia, including Hilmo

20.07

58.76

7.7

2.6

1266.82

1535.38

e6/l

0.50

Acute lymphocytic leukaemia, helper endpoint

20.07

58.76

7.7

2.6

1266.82

1535.37

e6/l

0.50

Acute lymphocytic leukaemia

20.07

58.76

7.7

2.6

1266.82

1535.38

e6/l

0.50

Hypothyroidism (congenital or acquired)

221

332

3.76

58.62

2.2

2.3

1305.25

1375.87

e6/l

0.52

181

279

Non-allergic asthma (mode)

166

416

4.00

57.93

1.6

2.3

1221.11

1134.24

e6/l

0.59

137

345

Asthma, including avohilmo

1070

3372

1.76

57.89

2.1

2.6

1284.23

1209.97

e6/l

1.08

903

2958

Unspecified acute lower respiratory infection

207

612

3.45

57.79

2.5

1320.44

1178.12

e6/l

1.31

174

528

Abnormal findings on examination of blood, without diagnosis

477

1943

2.24

57.39

2.5

2.4

1154.25

1142.70

e6/l

0.10

410

1733

Pulmonary heart disease, diseases of pulmonary circulation

317

1196

2.68

57.35

2.3

1436.63

1132.54

e6/l

0.51

295

1067

Idiopathic pulmonary fibrosis

112

209

5.51

57.27

1.7

2.0

1039.69

1096.97

e6/l

0.23

100

188

Hypothyroidism, levothyroxine purchases

217

329

3.73

56.98

2.2

2.3

1318.17

1374.00

e6/l

0.37

179

276

Hypothyroidism and >3 levothyroxin purchases

217

329

3.73

56.98

2.2

2.3

1318.17

1374.00

e6/l

0.37

179

276

Asthma/COPD (KELA code 203)

867

3169

1.84

56.94

2.0

2.6

1283.12

1216.85

e6/l

0.83

728

2766

Dermatitis due to substances taken internally

100

170

6.09

56.54

2.9

2.7

1188.26

1113.91

e6/l

0.34

147

Haemolytic anaemias

108

7.80

56.41

3.5

2.5

1117.97

1242.91

e6/l

0.45

Other arthritis (FG)

314

1191

2.67

56.25

2.1

2.6

1513.08

1208.81

e6/l

0.49

284

1046

Lung cancer and mesothelioma

154

308

4.29

56.25

2.0

2.1

982.73

1059.76

e6/l

0.52

144

278

Secondary thrombocytopenia

16.46

56.15

2.9

2.2

925.26

1106.46

e6/l

0.37

Other noninfective gastroenteritis and colitis

300

1117

2.72

55.76

2.5

2.7

1297.97

1217.83

e6/l

0.75

267

940

L01XX Other antineoplastic agents

159

6.26

55.73

2.6

1.9

2207.41

1137.99

e6/l

0.51

142

Other disorders of skin and subcutaneous tissue, not elsewhere classified

185

525

3.59

55.05

2.5

2.3

1196.33

1108.15

e6/l

0.57

168

462

Seropositive rheumatoid arthritis, wide

277

997

2.82

55.03

2.0

2.3

979.14

1182.63

e6/l

4.09

247

886

Care involving dialysis

126

270

4.81

55.01

2.4

2.9

1044.85

1212.33

e6/l

0.92

115

231

Other skin changes

234

771

3.09

54.62

2.6

2.4

1174.79

1161.36

e6/l

0.08

207

688

Intestinal infectious diseases, including avohilmo, including avohilmo

1018

3259

1.75

54.43

2.5

2.4

1258.96

1206.06

e6/l

0.63

874

2848

6-mercaptopurine

7.98

54.27

3.8

2.8

1012.39

1379.28

e6/l

2.32

Other disorders of skin and subcutaneous tissue

661

2883

1.95

54.23

2.4

1172.01

1192.32

e6/l

0.16

574

2542

Diseases of spleen

12.64

53.79

2.4

1.7

1224.69

1236.20

e6/l

0.02

Polyneuropathies and other disorders of the peripheral nervous system

244

832

2.98

53.61

3.2

2.4

1279.15

1103.36

e6/l

2.17

212

742

Other and unspecified iron deficiency

351

1435

2.47

53.56

2.7

2.4

1121.19

1193.35

e6/l

0.85

308

1246

Depression medications

237

349

3.44

53.46

2.9

2.3

1355.51

1350.78

e6/l

0.02

200

291

Other/unspecified seropositive rheumatoid arthritis

272

987

2.79

53.23

1.9

2.3

984.55

1182.34

e6/l

3.82

243

878

Other/unspecified seropositive rheumatoid arthritis (ICD-10)

269

974

2.80

52.87

1.9

2.3

980.67

1177.95

e6/l

3.77

240

866

Molar incisor enamel hypoplasia, with caries

9.89

51.90

6.1

2.5

1144.98

1629.39

e6/l

1.89

DVT of lower extremities and pulmonary embolism

376

1604

2.36

51.83

2.3

1394.69

1147.83

e6/l

0.47

344

1433

Other specified/unspecified arthritis

286

1085

2.67

51.30

2.1

2.5

1549.36

1169.98

e6/l

0.59

259

943

Symptoms and signs concerning food and fluid intake

124

277

4.55

51.10

2.9

2.1

1353.83

1244.39

e6/l

0.49

102

243

Symptoms and signs involving the digestive system and abdomen

865

2401

1.81

51.07

2.7

2.4

1221.16

1182.44

e6/l

0.56

734

2081

Other heart diseases, wide

838

2826

1.80

50.81

2.4

2.6

1130.30

1298.69

e6/l

3.28

719

2440

Syncope and collapse

322

1063

2.55

50.81

2.4

2.2

1184.42

1187.86

e6/l

0.02

279

939

Pulmonary embolism

287

1098

2.64

50.59

2.3

1462.64

1132.96

e6/l

0.50

268

981

Gastro-oesophageal reflux disease

618

2697

1.95

50.57

2.2

2.5

1290.81

1197.03

e6/l

1.06

547

2360

Malignant neoplasm of mesothelium and soft tissue, including Hilmo

134

6.43

50.50

2.3

2.0

865.58

1211.77

e6/l

2.70

115

Pulmonary heart disease

287

1099

2.64

50.50

2.3

1462.64

1137.43

e6/l

0.49

268

981

Diarrhoea and gastroenteritis of presumed infectious origin, including avohilmo

893

3277

1.76

50.15

2.4

1280.52

1202.51

e6/l

1.05

763

2863

Disturbances of skin sensation

298

1171

2.58

49.80

2.6

2.4

1319.02

1247.43

e6/l

0.74

247

1018

Elevated erythrocyte sedimentation rate and abnormality of plasma viscosity

112

237

4.85

49.64

2.6

2.0

1170.99

1096.91

e6/l

0.34

105

212

Asthma and allergy

130

304

4.28

49.57

1.8

2.6

1475.58

1213.78

e6/l

2.61

101

239

Symptoms and signs involving the urinary system

684

2760

1.88

49.52

2.7

2.4

1237.53

1197.15

e6/l

0.34

605

2434

Glomerular diseases

216

722

3.04

49.27

2.0

2.6

1172.72

1146.83

e6/l

0.14

197

627

Osteoporosis with pathological fracture (FG)

175

5.57

49.27

2.4

1.8

1014.35

1155.21

e6/l

0.73

156

Acute generalized exanthematous pustulosis

148

6.12

49.26

3.2

2.9

1191.99

1274.17

e6/l

0.28

133

Disorders of eyelid, lacrimal system and orbit

773

3153

1.81

49.00

2.7

2.4

1200.47

1205.30

e6/l

0.04

699

2760

Asthma and allergy, excluding more controls

130

307

4.24

48.97

1.8

2.6

1475.58

1229.39

e6/l

2.35

101

243

Other disorders of fluid, electrolyte and acid-base balance

304

1138

2.54

48.92

2.1

2.4

1454.89

1115.97

e6/l

0.54

275

1026

Generalized skin eruption due to drugs and medicaments

130

6.51

48.66

3.0

2.8

1230.50

1287.24

e6/l

0.16

115

Other problems related to primary support group, including family circumstances

187

563

3.31

48.40

4.0

2.5

1400.18

1389.71

e6/l

0.04

146

466

Malignant neoplasm of other connective and soft tissue

11.38

48.06

2.2

1.4

789.02

1502.90

e6/l

3.09

Malignant neoplasm of bronchus and lung, including Hilmo

149

321

3.91

48.03

2.0

985.35

1068.15

e6/l

0.58

139

284

Factors influencing health status and contact with health services

209

306

3.45

47.44

2.6

2.1

1270.81

1110.45

e6/l

1.29

186

274

Basal cell carcinoma, including Hilmo

292

751

2.65

47.39

2.0

1109.37

1121.53

e6/l

0.09

258

662

Other/unspecified rheumatoid arthritis

145

387

3.82

47.32

1.9

2.1

1003.86

1114.72

e6/l

0.81

129

345

Mycoses, including avohilmo

828

3626

1.75

47.30

2.4

1224.60

1222.47

e6/l

0.02

706

3184

All influenza (not pneumonia)

165

480

3.49

47.27

2.7

2.6

1231.15

1207.49

e6/l

0.12

142

398

Metabolic disorders

828

2820

1.77

47.14

2.3

2.5

1226.98

1174.98

e6/l

0.82

714

2459

Viral pneumonia (unknown virus, not influenza)

114

256

4.59

47.07

2.6

2.3

1023.82

1264.30

e6/l

2.43

101

222

Other functional intestinal disorders

440

1891

2.13

46.86

2.5

2.6

1242.18

1197.36

e6/l

0.47

372

1645

Haemorrhage from respiratory passages

310

1119

2.47

46.60

2.4

1480.72

1103.60

e6/l

0.61

269

993

Urticaria and erythema

389

1774

2.22

46.39

2.5

2.7

1291.10

1257.98

e6/l

0.31

320

1515

Secondary malignant neoplasm of other and unspecified sites, including Hilmo

175

518

3.31

45.96

1.8

2.0

921.88

1100.42

e6/l

2.51

166

457

Drug-induced cataract

8.82

45.89

3.3

2.1

1181.48

1169.74

e6/l

0.03

FESS (DNB20)

166

497

3.41

45.61

2.3

2.4

1338.42

1189.60

e6/l

1.41

144

446

Ethmoidectomy

170

517

3.36

45.55

2.3

2.5

1344.10

1192.89

e6/l

1.49

148

461

Pneumonia derived septicemia

116

6.67

45.51

2.4

3.0

1367.53

1236.77

e6/l

0.41

Pain in throat and chest

696

2241

1.85

45.44

2.4

2.5

1238.79

1196.90

e6/l

0.58

599

1934

Malignant neoplasm of mesothelium and soft tissue

8.68

45.25

2.3

1.8

778.75

1344.55

e6/l

3.47

Viral infections of the central nervous system

112

256

4.50

45.21

2.8

2.2

1358.54

1300.93

e6/l

0.26

226

Procreative management

382

1419

2.24

45.09

2.4

2.7

1339.26

1259.18

e6/l

0.90

310

1205

Budesonide

144

395

3.70

45.09

2.2

2.6

1029.92

1211.96

e6/l

1.87

124

350

Exfoliative dermatitis

16.44

44.80

2.9

2.1

1458.79

924.62

e6/l

0.66

Disorders of mineral metabolism

121

296

4.19

44.66

2.5

1070.00

1143.31

e6/l

0.40

109

262

Exclusions for E4_PCOS_BROAD

232

852

2.77

44.51

2.5

2.7

1274.63

1236.96

e6/l

0.25

191

719

Other viral diseases, not elsewhere classified

237

878

2.73

44.43

3.4

2.5

1383.84

1264.83

e6/l

0.82

201

728

Malignant neoplasm of other connective and soft tissue, including Hilmo

7.97

44.40

2.1

1.8

823.22

1277.97

e6/l

2.69

Viral infections of the central nervous system, including avohilmo

117

281

4.28

44.29

2.8

2.3

1368.12

1308.51

e6/l

0.29

246

Drugs, medicaments and biological substances causing adverse effects in therapeutic use

127

324

4.01

44.27

2.4

2.3

1300.25

1190.16

e6/l

0.57

108

283

Convulsions, not elsewhere classified

205

697

2.93

44.11

2.6

2.4

1308.64

1248.90

e6/l

0.36

168

607

Basal cell carcinoma

276

722

2.62

44.06

2.0

1083.40

1115.92

e6/l

0.26

244

635

Pleural effusion

162

488

3.37

43.99

2.3

2.2

983.91

1091.74

e6/l

0.77

148

442

Heart failure,strict

435

1436

2.13

43.88

2.1

2.4

962.15

1195.06

e6/l

2.53

393

1285

Abdominal and pelvic pain

833

2401

1.75

43.83

2.7

2.4

1213.03

1182.44

e6/l

0.43

720

2081

Other (seronegative) rheumatoid arthritis, wide

201

690

2.96

43.75

1.9

2.3

1020.23

1183.96

e6/l

1.67

176

612

Cellulitis

247

948

2.64

43.44

2.5

1189.45

1208.29

e6/l

0.10

219

824

Diseases of vocal cords and larynx+other diseases of upper respiratory tract, no elsewhere classified

462

2219

2.02

43.31

2.0

2.5

1320.75

1101.98

e6/l

5.10

408

1959

Sicca syndrome [Sjögren]

111

262

4.34

42.96

2.5

2.3

985.19

1134.12

e6/l

1.20

232

Other diseases of pericardium

120

6.28

42.73

2.3

1052.49

1283.31

e6/l

0.89

103

Codeine or tramadol medication

927

3017

1.68

42.63

2.3

1264.99

1203.05

e6/l

0.74

806

2660

Noninfectious colitis NAS

167

525

3.24

42.37

2.7

2.6

1329.93

1204.19

e6/l

0.88

148

451

Chronic rhinitis, nasopharyngitis and pharyngitis

323

1417

2.30

42.34

1.9

2.6

1398.67

1123.50

e6/l

5.50

272

1216

Disorders of sclera, cornea, iris and ciliary body

503

2611

1.94

42.23

2.6

2.4

1239.48

1162.76

e6/l

1.17

450

2270

Pneumococcal septicemia

112

6.54

42.22

2.5

2.9

1381.77

1253.70

e6/l

0.33

Neurotic, stress-related and somatoform disorders

783

3150

1.72

41.69

2.7

2.4

1341.47

1205.32

e6/l

2.43

692

2728

Acute tubulo-interstitial nephritis

527

2336

1.92

41.39

2.4

1195.16

1242.58

e6/l

0.35

467

2029

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified (FINNGEN)

388

1121

2.20

41.31

2.4

2.8

1150.31

1241.80

e6/l

1.18

340

969

Extracorporeal dialysis

100

225

4.59

41.28

2.5

2.4

1076.93

1203.29

e6/l

0.49

199

COPD (mode)

191

496

3.02

41.03

1.8

2.2

1197.98

1103.69

e6/l

0.69

172

451

Disorders of calcium metabolism

214

4.66

40.96

2.3

1076.38

1117.45

e6/l

0.17

188

Other viral diseases, not elsewhere classified, including avohilmo

306

1330

2.31

40.46

3.0

2.6

1390.33

1292.71

e6/l

0.82

257

1101

Anxiety disorders, excluding more controls

718

2626

1.76

40.42

2.7

2.3

1327.68

1183.64

e6/l

2.24

636

2300

Disorders of thyroid, IBD co-morbidities

137

247

3.83

40.35

2.3

2.1

1205.92

1198.40

e6/l

0.03

118

210

Squamous cell neoplasms and carcinomas of the skin, including Hilmo

179

4.92

40.07

2.2

1.7

1004.17

989.78

e6/l

0.06

161

Anxiety disorders

784

3180

1.70

39.91

2.7

2.4

1342.46

1202.14

e6/l

2.58

693

2757

Pain in joint

497

1557

1.97

39.80

2.2

2.4

1285.73

1134.05

e6/l

3.18

435

1356

Complications of procedures, not elsewhere classified

668

3071

1.76

39.77

2.1

2.3

1215.49

1213.79

e6/l

0.01

591

2687

Other infectious diseases

102

241

4.33

39.46

2.9

2.2

1111.23

1186.25

e6/l

0.35

213

Low back pain

669

2563

1.77

39.26

2.4

1268.22

1211.26

e6/l

0.54

581

2243

Hypoplasia of dental enamel

114

7.09

39.19

6.0

3.4

1023.65

1538.15

e6/l

2.78

Dysphagia

233

914

2.58

39.18

2.2

2.3

1225.60

1133.66

e6/l

0.75

198

810

Nonsuppurative otitis media

267

956

2.45

39.16

2.7

2.5

1300.16

1295.23

e6/l

0.03

222

794

Neuromuscular dysfunction of bladder

119

317

3.84

39.07

3.0

2.3

1287.26

1134.54

e6/l

0.98

100

279

Biological medication for rheuma

218

831

2.66

38.99

1.8

2.7

1251.05

1245.67

e6/l

0.02

190

706

Other soft tissue disorders, not elsewhere classified

815

2758

1.69

38.99

2.5

1302.09

1224.16

e6/l

0.91

706

2370

Postprocedural disorders of nervous system

110

278

4.06

38.94

2.5

1244.77

1359.05

e6/l

0.71

239

Abnormal findings on diagnostic imaging of other body structures

152

476

3.24

38.83

2.6

2.3

1029.27

1215.39

e6/l

1.96

135

411

Malignant neoplasm, without specification of site, including Hilmo

7.96

38.77

3.2

2.4

1077.02

1170.08

e6/l

0.29

Other specific joint derangements/joint disorders

643

2250

1.79

38.48

2.3

2.5

1300.40

1205.01

e6/l

1.76

565

1936

Viral warts

133

386

3.52

38.45

2.5

1191.92

1274.60

e6/l

0.47

118

333

Non-small cell lung cancer, including Hilmo

107

249

4.07

37.91

2.0

1.8

941.04

1094.95

e6/l

1.18

220

5-aminosalicylic acid

184

653

2.85

37.67

2.0

2.8

1208.12

1228.30

e6/l

0.10

156

571

Other complications of surgical and medical care, not elsewhere classified

126

358

3.59

37.63

2.3

1190.43

1199.08

e6/l

0.03

106

309

Other and unspecified polyneuropathies, also in other diseases

194

711

2.77

37.47

3.0

2.3

1314.22

1086.17

e6/l

2.69

170

637

Secondary hypertension

101

242

4.19

37.40

1.9

3.0

1160.92

1245.71

e6/l

0.31

206

Other diseases of upper respiratory tract

874

2780

1.64

37.17

2.5

1349.31

1156.89

e6/l

3.91

761

2426

Conjunctivitis (acute, non atopic)

309

1401

2.22

37.14

2.4

2.6

1251.36

1279.99

e6/l

0.23

278

1181

Stomatitis and related lesions

227

904

2.55

37.12

3.4

2.5

1188.74

1215.15

e6/l

0.17

186

775

Persons encountering health services in other circumstances

362

1738

2.08

36.78

2.3

2.5

1251.44

1202.98

e6/l

0.49

334

1489

8.79

36.75

1.6

2.2

1623.10

1113.53

e6/l

2.37

Hypertensive diseases (excluding secondary)

445

1303

2.00

36.56

2.1

2.8

1275.65

1265.38

e6/l

0.07

382

1113

159

532

3.03

36.32

2.4

2.5

1212.82

1225.79

e6/l

0.05

137

455

Subjective visual disturbances

253

1072

2.39

36.10

2.5

1314.49

1190.71

e6/l

1.21

218

928

Malignant neoplasm of bronchus and lung

122

281

3.66

36.10

1.8

1.9

953.85

1077.92

e6/l

1.04

117

249

Disorders of oesophagus in diseases classified elsewhere

9.09

36.06

1.6

2.0

1306.58

1152.98

e6/l

0.37

Bleeding

686

2826

1.71

35.98

2.4

2.5

1272.42

1166.13

e6/l

0.33

600

2482

Other and unspecified drugs and medicaments

114

313

3.73

35.88

2.4

1324.01

1244.76

e6/l

0.33

275

Glomerular disorders in diseases classified elsewhere

139

434

3.26

35.79

1.9

2.6

1049.69

1113.58

e6/l

0.40

124

385

Vocal cord dysfunction

132

344

3.42

35.64

1.8

3.1

1293.41

1202.02

e6/l

0.57

113

315

Other symptoms and signs involving the digestive system and abdomen

167

583

2.90

35.33

3.0

2.5

1213.50

1209.99

e6/l

0.02

149

508

Recurrent aphthous stomatitis , including avohilmo

173

617

2.85

35.26

3.6

2.4

1225.40

1226.65

e6/l

0.01

144

525

Other infectious diseases, including avohilmo

113

312

3.70

35.25

2.8

2.3

1125.44

1207.61

e6/l

0.42

101

270

Hypoparathyroidism

116

5.82

35.10

1.7

1.9

1035.34

1197.52

e6/l

0.75

Malignant neoplasm of head and neck, including Hilmo

183

4.60

34.95

2.2

2.1

1223.99

1127.52

e6/l

0.36

162

Other disorders of urethra and urinary system

582

2289

1.78

34.93

2.3

1230.28

1174.84

e6/l

0.73

507

2024

Diseases of the musculoskeletal system and connective tissue

465

1196

1.96

34.88

2.6

2.5

1308.52

1262.59

e6/l

0.41

382

986

Episodal and paroxysmal disorders

900

2854

1.61

34.68

2.4

2.5

1316.46

1183.61

e6/l

3.80

788

2451

Mixed connective tissue disease

10.81

34.50

2.2

867.45

1148.22

e6/l

1.01

Obesity related asthma

314

1486

2.13

34.27

1.9

2.6

1444.54

1153.15

e6/l

5.56

276

1313

Presence of other functional implants

449

1614

1.92

33.99

2.1

1133.27

1178.16

e6/l

0.26

415

1445

Iridocyclitis

228

953

2.42

33.61

2.2

2.5

1225.03

1187.22

e6/l

0.26

208

830

L01XE Protein kinase inhibitors

174

4.69

33.55

4.5

1.9

2244.43

1135.88

e6/l

0.45

154

Cutaneous abscess, furuncle and carbuncle

264

1179

2.26

33.37

2.3

2.6

1197.62

1225.45

e6/l

0.19

222

1024

Hypercalcemia

137

5.20

33.13

2.4

2.1

1046.47

1150.26

e6/l

0.35

121

Chronic iridocyclitis

150

4.94

32.66

2.0

2.3

1252.57

1269.45

e6/l

0.04

136

Acute suppurative otitis media

287

1241

2.18

32.59

2.9

2.6

1373.78

1312.49

e6/l

0.52

247

1033

Unspecified kidney failure

108

305

3.60

32.56

2.4

2.2

1113.21

1094.05

e6/l

0.08

264

Hypothyroidism, strict autoimmune

470

1665

1.86

32.37

2.2

2.3

1185.90

1265.68

e6/l

0.56

408

1453

Osteonecrosis

204

4.27

32.32

2.8

2.0

1093.06

1188.98

e6/l

0.44

186

Migraine

451

1894

1.86

32.27

2.3

2.5

1570.14

1222.03

e6/l

0.91

386

1620

Pneumonia due to Streptococcus pneumoniae

105

5.77

31.87

2.8

2.3

1366.83

1262.38

e6/l

0.34

Diseases of middle ear and mastoid

523

2429

1.77

31.81

2.4

1263.33

1248.53

e6/l

0.15

452

2083

Pain in limb

700

2704

1.65

31.77

2.6

2.5

1272.14

1224.03

e6/l

0.45

604

2328

Childhood asthma (age<16)

120

276

3.43

31.63

2.1

2.6

1349.69

1280.15

e6/l

0.36

211

Nonsuppurative otitis media, including avohilmo

321

1353

2.07

31.57

2.4

2.5

1325.29

1284.71

e6/l

0.34

265

1137

Molar incisor enamel hypoplasia

253

3.87

31.54

4.9

3.1

1122.86

1593.27

e6/l

3.87

187

Malignant neoplasm of digestive organs, including Hilmo

241

757

2.35

31.52

2.2

2.1

1108.31

1124.92

e6/l

0.09

223

671

Antihypertensive medication - note that there are other indications

559

1653

1.78

31.44

2.4

2.7

1332.85

1318.30

e6/l

0.07

473

1397

Dermatopolymyositis

9.83

31.24

2.1

1.9

1008.81

1116.47

e6/l

0.27

Childhood asthma (age<16), excluding more controls

119

275

3.41

31.14

2.1

2.6

1314.64

1285.49

e6/l

0.14

211

Etanercept

259

3.80

31.10

1.7

2.9

1314.54

1282.17

e6/l

0.09

223

Use of amantadine

8.52

31.05

4.4

1.6

1450.58

1186.89

e6/l

1.09

Tumor necrosis factor alpha inhibitors

188

747

2.55

31.02

1.8

2.6

1261.85

1252.08

e6/l

0.04

163

643

Malignant neoplasm of bone and articular cartilage, including Hilmo

9.91

30.83

3.1

2.0

985.32

1624.84

e6/l

1.90

Other abnormal findings of blood chemistry

158

4.69

30.71

2.5

2.3

1138.65

1244.64

e6/l

0.39

145

Heart failure, strict

444

1674

1.85

30.59

2.1

2.4

960.79

1177.66

e6/l

2.72

402

1500

Other disorders of optic [2nd] nerve and visual pathways

240

3.89

30.46

3.5

2.3

1431.23

1311.04

e6/l

0.43

199

Lung diseases due to external agents

136

461

2.99

30.44

2.0

2.2

963.72

1125.27

e6/l

1.36

127

410

Use of hypnotics and sedatives

848

3106

1.57

30.33

2.4

1225.07

1214.64

e6/l

0.08

728

2733

Cerebrovascular diseases (FINNGEN)

253

785

2.28

30.26

2.3

2.9

1222.94

1213.71

e6/l

0.05

220

687

Lower back pain or/and sciatica

858

3448

1.55

30.03

2.4

2.3

1267.76

1201.80

e6/l

0.89

748

3034

Abnormality of white blood cells, not elsewhere classified

10.69

29.92

4.3

1.9

1161.32

1192.52

e6/l

0.05

Disorders of conjunctiva

708

3427

1.61

29.92

2.4

2.5

1264.05

1239.83

e6/l

0.22

607

2966

Seronegative rheumatoid arthritis

115

357

3.27

29.92

2.0

2.6

1074.03

1233.02

e6/l

0.95

101

324

Kidney transplant status

227

3.95

29.65

2.3

3.0

1161.14

1239.51

e6/l

0.23

190

Pain (limb, back, neck, head abdominally)

564

1629

1.74

29.51

2.8

2.4

1265.54

1148.98

e6/l

1.97

473

1409

All-cause Heart Failure

434

1648

1.84

29.35

2.1

2.4

959.40

1182.20

e6/l

2.80

394

1475

Localized swelling, mass and lump of skin and subcutaneous tissue

284

1376

2.08

29.23

2.8

2.3

1154.24

1195.68

e6/l

0.38

248

1204

Suppurative and unspecified otitis media

350

1605

1.95

29.22

2.7

2.5

1348.15

1272.71

e6/l

0.84

304

1346

Nerve, nerve root and plexus disorders

830

3216

1.56

29.15

2.3

2.4

1218.15

1206.96

e6/l

0.10

734

2823

Disorders of ocular muscles, binocular movement, accommodation and refraction

442

2459

1.79

29.14

3.0

2.5

1307.41

1240.07

e6/l

0.85

378

2097

Other diseases of lip and oral mucosa

370

1969

1.89

29.06

2.5

1175.69

1186.11

e6/l

0.08

320

1722

Urticaria

296

1460

2.05

29.04

2.5

2.7

1365.25

1270.28

e6/l

1.07

242

1240

Diseases of the digestive system

379

2016

1.88

29.02

2.3

2.5

1110.71

1163.83

e6/l

0.61

342

1758

Heart failure and antihypertensive medication

224

617

2.38

29.02

2.4

2.6

938.41

1224.70

e6/l

1.07

201

546

Polyuria

205

874

2.37

28.98

3.2

2.3

1371.34

1097.21

e6/l

3.01

184

780

Disorders of lens

514

1828

1.75

28.83

2.4

1176.40

1132.27

e6/l

0.47

458

1635

Covid-19 suspected case

215

940

2.31

28.69

2.2

2.6

1211.30

1262.80

e6/l

0.37

175

807

Diplopia

138

488

2.87

28.67

2.6

2.4

1258.37

1138.94

e6/l

0.99

120

429

Other neurological diseases

563

2603

1.69

28.67

2.4

1160.31

1174.44

e6/l

0.10

498

2296

Systemic sclerosis (FG)

7.41

28.59

1.9

2.4

1145.29

1148.13

e6/l

0.01

Inflammatory bowel disease

295

1465

2.03

28.42

2.2

2.7

1201.21

1219.62

e6/l

0.13

257

1258

Diseases of the ear and mastoid process

904

2973

1.53

28.31

2.3

2.4

1225.47

1223.86

e6/l

0.01

778

2587

Secondary malignant neoplasm of respiratory and digestive organs, including Hilmo

117

381

3.10

28.05

1.8

2.0

928.02

1107.07

e6/l

2.11

110

337

Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure

459

2632

1.75

27.88

2.2

2.3

1199.92

1147.18

e6/l

0.62

406

2314

COPD, hospital admissions 3, with asthma pneumonia sepsis

220

832

2.29

27.81

1.8

2.2

1266.49

1064.45

e6/l

2.53

200

752

Iron deficiency anaemia secondary to blood loss (chronic)

150

563

2.70

27.79

1.8

2.3

977.66

1132.76

e6/l

1.73

137

491

Other and unspecified tonsillitis

286

1163

2.06

27.69

2.5

2.4

1349.27

1275.51

e6/l

0.73

254

982

Collagenous colitis

107

334

3.26

27.68

2.3

2.4

1269.91

1209.46

e6/l

0.25

294

Meningitis

155

4.50

27.68

1.9

2.3

1336.21

1294.60

e6/l

0.12

136

Malignant neoplasm of urinary organs, including Hilmo

206

3.93

27.57

2.3

1.9

1028.00

1130.87

e6/l

0.56

187

Special screening examination for infectious and parasitic diseases

184

539

2.51

27.54

2.1

1509.40

1186.09

e6/l

5.36

154

457

Other diseases of urinary system

793

2874

1.55

27.44

2.7

2.4

1224.25

1184.09

e6/l

0.59

689

2523

Persons with potential health hazards related to communicable diseases

368

1976

1.86

27.31

2.8

2.5

1688.19

1300.36

e6/l

0.74

301

1658

Myasthenia gravis

7.85

27.00

3.1

1.8

1101.33

1399.30

e6/l

0.65

Anterior Iridocyclitis

196

850

2.33

26.71

2.2

2.5

1212.24

1198.55

e6/l

0.07

180

738

Allergic bronchopulmonary aspergillosis (ABPA)

54.77

26.68

2.7

2.3

973.64

1190.00

e6/l

—

Intracranial trauma

415

1553

1.81

26.63

2.3

1299.06

1179.24

e6/l

1.38

355

1318

Other pleural conditions

297

3.35

26.57

2.2

2.1

872.32

1133.50

e6/l

2.52

264

Systemic sclerosis

6.82

26.56

1.9

2.3

1145.29

1129.95

e6/l

0.03

Carrier of infectious disease

5.95

26.52

2.3

3543.05

1269.51

e6/l

0.51

Epilepsy

279

1388

2.02

26.51

2.3

2.7

1538.48

1200.43

e6/l

0.46

241

1184

Pericarditis

5.65

26.42

2.3

3.0

906.56

1336.61

e6/l

2.24

Later onset COPD, excluding more controls

117

290

3.10

26.22

1.8

2.1

1093.45

1072.52

e6/l

0.09

109

263

Small fibre neuropathy

5.64

26.19

3.9

2.1

1315.36

1324.61

e6/l

0.02

Lack of expected normal physiological development

5.93

26.16

4.5

2.1

1626.37

1742.72

e6/l

0.23

Hypoplasia of dental enamel , including avohilmo

247

3.61

26.08

5.2

3.1

1074.06

1590.98

e6/l

4.88

181

Mood disorders, excluding more controls

729

2753

1.56

26.04

2.6

2.3

1315.89

1171.60

e6/l

2.38

633

2419

Combined immunodeficiencies

10.70

25.90

3.9

1.9

1249.59

1338.00

e6/l

0.11

Atrial fibrillation and flutter

235

691

2.21

25.81

2.4

2.9

1039.92

1170.15

e6/l

1.50

211

616

Continuous positive airway pressure

164

548

2.52

25.53

2.5

2.7

1433.69

1197.67

e6/l

1.73

145

471

Diseases of veins, lymphatic vessels and lymph nodes, not elsewhere classified

735

3016

1.55

25.46

2.3

2.4

1114.36

1189.05

e6/l

1.26

646

2661

Constipation

711

3114

1.55

25.45

2.2

2.5

1150.86

1221.23

e6/l

0.86

606

2736

Viral warts, including avohilmo

214

983

2.20

25.41

2.6

2.7

1184.56

1264.71

e6/l

0.69

188

837

Hypothyroidism, drug reimbursement

203

3.43

25.36

2.3

2.4

1043.35

1300.77

e6/l

2.68

176

Dorsalgia

768

2650

1.54

25.31

2.5

2.4

1298.22

1214.08

e6/l

1.00

665

2307

Chronic ulcer of skin, not elsewhere classified

215

3.75

25.29

2.1

2.0

1049.67

1101.39

e6/l

0.25

192

Malignant neoplasm of head and neck

149

4.35

25.27

2.2

2.0

1205.61

1131.21

e6/l

0.22

131

Persons with potential health hazards related to socioeconomic and psychosocial circumstances

276

1381

1.99

25.21

3.6

2.5

1422.63

1330.72

e6/l

0.73

218

1157

Conjunctivitis

632

3233

1.58

25.15

2.4

2.5

1276.74

1252.37

e6/l

0.21

540

2788

Non-small cell lung cancer

164

4.14

25.15

1.6

1.7

887.79

1053.09

e6/l

1.11

146

Viral meningitis

122

4.82

25.14

2.8

2.3

1369.02

1336.91

e6/l

0.09

113

Keratitis and keratoconjunctivitis in other diseases classified elsewhere

103

5.19

25.07

2.8

2.1

1252.04

1207.29

e6/l

0.11

Glomerulonephritis

115

398

2.94

24.97

2.2

2.7

1258.39

1186.58

e6/l

0.30

106

342

Depression

757

3332

1.52

24.89

2.6

2.4

1319.63

1192.31

e6/l

2.28

652

2917

Eosinophilia

8.12

24.89

1.9

2.0

1110.93

1104.51

e6/l

0.01

Benign neoplasms

780

2796

1.52

24.57

2.2

2.5

1191.42

1216.48

e6/l

0.33

663

2439

Acute pharyngitis

151

599

2.52

24.50

2.5

1333.33

1248.27

e6/l

0.53

129

491

Otitis media, unspecified

137

479

2.67

24.49

3.1

2.5

1466.46

1340.20

e6/l

0.67

114

386

Ulcerative colitis, NAS

148

589

2.55

24.45

2.1

2.5

1226.30

1174.54

e6/l

0.27

128

505

Disorders of parathyroid gland

166

688

2.41

24.37

2.1

2.3

1088.27

1149.96

e6/l

0.43

153

611

Hypo-osmolality and hyponatraemia

152

609

2.50

24.26

2.4

1789.65

1118.33

e6/l

0.53

135

546

Viral meningitis, including avohilmo

134

4.54

24.21

2.8

2.3

1384.96

1336.83

e6/l

0.15

122

Acute and subacute iridocyclitis

179

781

2.32

24.11

2.2

2.5

1213.78

1180.65

e6/l

0.19

165

679

291

1365

1.93

23.95

2.2

1077.55

1148.59

e6/l

0.37

260

1235

Acute lymphadenitis

210

3.70

23.85

3.2

2.8

1150.63

1310.10

e6/l

0.79

181

Systemic sclerosis, icd10

6.06

23.71

1.9

2.1

1145.29

1131.41

e6/l

0.03

Non-ischemic cardiomyopathy

246

955

2.06

23.69

2.3

2.4

996.40

1226.09

e6/l

1.36

222

857

Malignant neoplasm of kidney, except renal pelvis, including Hilmo

184

3.85

23.50

2.4

1.9

1035.95

1107.15

e6/l

0.31

165

Diseases of liver

293

1553

1.90

23.44

2.1

2.5

1155.79

1172.64

e6/l

0.12

255

1370

Arthropathies

710

2334

1.54

23.33

2.4

2.6

1298.01

1214.62

e6/l

1.40

617

1996

Other and unspecified urticaria

196

901

2.20

23.30

2.2

2.7

1390.58

1256.81

e6/l

1.25

165

769

Iridocyclitis in diseases classified elsewhere

6.77

23.20

1.8

2.1

1130.13

1173.86

e6/l

0.10

Malignant neoplasm of digestive organs

202

705

2.20

23.04

2.0

1140.71

1118.36

e6/l

0.10

185

623

Skin changes due to chronic exposure to nonionizing radiation

272

1273

1.95

23.02

2.1

1046.02

1150.91

e6/l

0.58

244

1156

Mood disorders

793

3422

1.49

23.01

2.6

2.3

1323.63

1189.15

e6/l

2.62

683

3001

COPD, hospital admission 2, with asthma infections

240

1021

2.04

22.90

1.8

2.3

1259.94

1085.73

e6/l

2.22

216

920

Dental operations

415

1220

1.76

22.67

2.5

2.1

1149.65

1185.53

e6/l

0.30

370

1037

Concussion

353

1531

1.80

22.66

2.4

2.3

1326.18

1178.43

e6/l

1.60

303

1300

Mood [affective] disorders

789

3419

1.48

22.64

2.6

2.3

1325.47

1188.59

e6/l

2.68

679

2998

Malignant neoplasm, without specification of site

7.90

22.59

3.5

1.6

1060.36

1230.79

e6/l

0.38

Papulosquamous disorders

318

1751

1.83

22.56

2.2

2.4

1190.87

1173.42

e6/l

0.11

282

1541

Endocrine, nutritional and metabolic diseases

634

2048

1.57

22.43

2.6

1311.69

1206.89

e6/l

1.71

533

1747

Functional dyspepsia

221

1080

2.06

22.38

2.1

2.4

1273.80

1167.65

e6/l

1.17

188

951

Chronic apical periodontitis

842

3230

1.47

22.26

2.4

2.3

1190.62

1224.06

e6/l

0.35

745

2812

Vasomotor and allergic rhinitis

312

1675

1.83

22.19

2.1

2.6

1381.55

1160.44

e6/l

4.93

267

1425

Valvular heart disease excluding rheumatic fever

357

1435

1.79

22.15

2.3

2.7

1026.70

1252.12

e6/l

1.96

321

1273

Crohn disease

137

554

2.51

21.95

2.4

2.6

1118.94

1202.09

e6/l

0.49

125

471

Actinic keratosis

261

1234

1.94

21.80

2.1

986.16

1151.53

e6/l

1.19

234

1120

Cardiac arrhythmias

485

1902

1.64

21.76

2.3

2.7

1196.14

1247.74

e6/l

0.62

415

1636

Hypokalaemia

113

418

2.74

21.67

1.8

2.4

1267.81

1141.05

e6/l

0.78

103

373

Somatoform disorder

150

638

2.38

21.49

2.0

2.6

1471.06

1204.43

e6/l

2.16

126

556

Other metabolic disorders

133

536

2.51

21.46

3.1

2.5

1210.11

1227.91

e6/l

0.09

109

468

Other antidepressants

769

2651

1.49

21.31

2.4

2.3

1270.29

1176.66

e6/l

1.15

661

2353

Hypertension, essential

576

2078

1.57

21.17

2.1

2.6

1209.61

1244.68

e6/l

0.24

503

1814

Symptoms and signs involving speech and voice

266

1415

1.89

21.11

2.0

2.4

1181.76

1188.63

e6/l

0.05

229

1250

Diseases of arteries, arterioles and capillaries (FINNGEN)

178

547

2.26

21.09

2.0

2.9

1032.35

1167.58

e6/l

1.34

157

491

Irritable bowel syndrome

228

1152

1.99

21.08

2.1

2.5

1345.22

1212.05

e6/l

1.58

193

1001

Ocular pain

321

2.98

20.97

3.0

2.7

1387.75

1257.75

e6/l

0.80

271

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperum or nerve system disorders, excluding more controls

226

1127

1.99

20.86

2.3

2.4

1440.46

1211.44

e6/l

3.96

189

972

Other CVD (FINNGEN)

252

3.00

20.83

1.7

2.6

1226.32

1137.37

e6/l

0.36

229

Malignant neoplasm of urinary organs

177

3.71

20.79

1.8

1.9

1045.98

1100.35

e6/l

0.22

158

Non-rheumatic valve diseases

346

1404

1.77

20.77

2.3

2.6

1035.05

1246.42

e6/l

1.72

313

1247

Gastric ulcer

137

568

2.43

20.76

2.0

2.2

963.66

1068.26

e6/l

0.84

122

513

Viral and other specified intestinal infections

201

953

2.08

20.65

2.7

1300.16

1299.00

e6/l

0.01

179

800

Other headache syndromes

324

1838

1.77

20.57

2.3

2.5

1429.80

1182.55

e6/l

4.82

273

1597

Abnormal results of function studies

314

2.98

20.54

2.3

2.7

1287.07

1253.84

e6/l

0.11

269

Hypertension

602

2211

1.54

20.27

2.1

2.6

1220.80

1262.34

e6/l

0.30

518

1904

Myalgia

206

1020

2.04

20.19

2.2

2.5

1417.37

1194.34

e6/l

2.91

184

886

COPD

306

1386

1.80

20.12

1.7

2.4

1194.27

1076.15

e6/l

1.55

275

1250

Postprocedural endocrine and metabolic disorders, not elsewhere classified

122

487

2.54

20.12

2.9

2.4

1210.66

1208.98

e6/l

0.01

100

431

Diseases of the myoneural junction and muscle

116

452

2.60

20.12

2.5

1136.46

1124.18

e6/l

0.06

103

401

Hypertensive diseases

602

2216

1.54

20.09

2.1

2.6

1221.49

1262.67

e6/l

0.30

518

1909

Myeloproliferative diseases

261

3.15

20.00

3.7

2.0

2196.17

1167.06

e6/l

0.41

234

Suppurative and necrotic conditions of lower respiratory tract

183

3.63

19.90

1.8

2.4

1056.45

1148.05

e6/l

0.35

163

Drug-induced polyneuropathy

7.97

19.82

6.1

4.0

1130.95

1115.25

e6/l

0.02

Soft tissue disorders

789

2785

1.46

19.80

2.6

2.5

1304.06

1225.10

e6/l

0.92

687

2391

Seropositive rheumatoid arthritis, strict definition

133

557

2.42

19.78

2.3

2.4

942.00

1211.66

e6/l

3.90

118

493

Rash and other nonspecific skin eruption

100

365

2.78

19.76

3.0

2.4

1222.94

1195.92

e6/l

0.10

315

Other general symptoms and signs

141

4.00

19.75

2.0

2.2

1373.27

1402.07

e6/l

0.07

121

Congenital malformations, deformations and chromosomal abnormalities

479

2893

1.58

19.51

2.4

2.5

1282.75

1242.22

e6/l

0.49

413

2485

Simple and mucopurulent chronic bronchitis

123

4.24

19.38

2.1

2.8

1676.93

1107.07

e6/l

2.52

101

Senile cataract

429

1591

1.65

19.35

2.3

2.4

1149.25

1094.86

e6/l

0.55

386

1439

Other joint disorders

661

2308

1.50

19.26

2.4

2.6

1320.96

1212.79

e6/l

2.24

578

1983

Polyarthrosis

151

603

2.27

19.25

2.0

2.4

1110.83

1122.63

e6/l

0.05

139

544

Other and unspecified diseases of blood and blood-forming organs

5.70

19.25

2.0

1449.87

1209.02

e6/l

0.53

Sequelae of external causes of morbidity and mortality

215

1101

1.97

19.20

2.6

2.4

1292.67

1178.00

e6/l

0.85

182

973

Spondylopathies

554

2126

1.55

19.16

2.1

2.4

1250.56

1179.12

e6/l

0.54

488

1879

Abnormalities of heart beat

249

1299

1.87

19.00

1.9

2.5

1195.73

1159.46

e6/l

0.29

214

1135

Urinary track infection

443

1358

1.64

18.90

2.7

2.2

1293.74

1266.48

e6/l

0.24

373

1171

Chronic diseases of tonsils and adenoids

589

2458

1.52

18.90

2.7

2.6

1378.93

1185.11

e6/l

2.91

514

2133

Disorders of gallbladder, biliary tract and pancreas

721

3091

1.46

18.88

2.4

1164.63

1209.31

e6/l

0.46

638

2726

Malignant neoplasm of kidney, except renal pelvis

166

3.65

18.79

1.8

1032.09

1095.22

e6/l

0.24

148

Migraine without aura

182

886

2.07

18.73

2.4

2.7

1422.79

1239.14

e6/l

1.84

145

740

Adalimumab

108

422

2.60

18.69

2.1

2.7

1248.25

1260.34

e6/l

0.04

367

Spondyloarthritis

132

565

2.36

18.67

1.6

2.2

1167.69

1236.12

e6/l

0.36

114

483

Disorders of skin appendages

406

2510

1.62

18.57

2.3

2.5

1286.26

1219.06

e6/l

0.83

351

2163

Gastroduodenal ulcer

179

868

2.07

18.43

1.9

2.2

961.19

1099.44

e6/l

1.58

160

780

Other dorsopathies, not elsewhere classified

742

2668

1.45

18.30

2.4

1290.99

1214.45

e6/l

0.88

636

2322

Misadventures to patients during surgical and medical care

126

534

2.39

18.29

2.2

1146.18

1120.98

e6/l

0.12

111

470

Retention of urine

248

1084

1.86

18.11

2.1

2.3

1125.62

1085.15

e6/l

0.33

214

985

Congenital malformations, deformations and chromosomal abnormalities, including avohilmo

512

3065

1.53

18.09

2.4

2.5

1311.99

1229.95

e6/l

1.02

440

2644

Keratitis

287

1643

1.76

17.99

2.8

2.5

1269.27

1210.42

e6/l

0.54

253

1426

Sequelae with surgical and medical care as external cause

171

828

2.08

17.91

2.7

2.4

1222.54

1159.69

e6/l

0.37

147

738

Paralytic ileus and intestinal obstruction

187

934

2.01

17.90

2.4

1060.52

1151.44

e6/l

0.87

172

830

Other disorders of ear

689

3079

1.45

17.86

2.4

2.5

1195.19

1203.17

e6/l

0.06

610

2678

Volume depletion

312

2.82

17.79

1.9

2.4

1021.21

1155.23

e6/l

0.76

274

L04AC Interleukin inhibitors

259

3.03

17.74

1.7

2.9

1335.01

1278.78

e6/l

0.15

229

Diaphragmatic hernia

259

1445

1.80

17.73

2.3

1172.09

1127.88

e6/l

0.36

226

1302

Biological medicines for asthma

5.04

17.70

1.3

2.6

1673.34

1247.42

e6/l

1.61

Hard cardiovascular diseases

618

2469

1.48

17.70

2.1

2.6

1165.09

1186.92

e6/l

0.20

550

2154

Ulcerative colitis

206

1071

1.94

17.65

2.0

2.6

1260.35

1203.03

e6/l

0.38

175

919

Erythema multiforme

5.39

17.61

2.4

1171.04

1274.84

e6/l

0.22

Other disorders of eye and adnexa

138

619

2.25

17.58

2.8

2.4

1416.21

1234.33

e6/l

1.24

118

521

Viral and other specified intestinal infections, including avohilmo

246

1302

1.83

17.55

2.6

2.7

1320.92

1279.73

e6/l

0.29

215

1088

Viral hepatitis, IBD co-morbidity

4.52

17.52

3.5

2.5

1473.55

1118.80

e6/l

1.08

Complications of internal orthopaedic prosthetic devices, implants and grafts

162

776

2.10

17.45

1.9

2.1

1145.34

1113.27

e6/l

0.15

139

695

Fentanyl

266

2.96

17.39

2.4

2.2

1132.76

1045.97

e6/l

0.39

232

Temporomandibular joint disorders, including avohilmo

360

2138

1.64

17.36

2.0

2.4

1390.32

1242.75

e6/l

2.57

321

1835

Follow-up examination after treatment for conditions other than malignant neoplasms

250

904

1.85

17.30

2.7

2.1

1368.57

1119.92

e6/l

2.82

210

802

Other/unspecified dorsalgia

278

1575

1.75

17.26

2.4

2.5

1393.82

1163.30

e6/l

1.98

244

1383

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified

192

3.38

17.20

2.9

3.0

1533.90

1473.66

e6/l

0.17

143

Weight loss

102

404

2.56

17.20

2.8

2.5

1327.66

1198.03

e6/l

0.57

349

Exposure to unspecified factor

779

3779

1.41

17.19

2.2

2.5

1277.49

1220.64

e6/l

0.62

661

3300

Speech and linguistic disorders, excluding more controls

339

2.67

17.14

3.8

2.6

1522.57

1322.26

e6/l

0.74

262

Hypopituitarism

342

2.71

17.09

2.6

2.9

1286.84

1248.59

e6/l

0.15

293

Other embolism and thrombosis

109

447

2.47

17.05

2.1

2.4

1020.45

1151.37

e6/l

1.03

399

Dialysis

164

3.57

17.00

2.3

2.7

1241.69

1200.19

e6/l

0.08

135

Diseases of oral cavity, salivary glands and jaws

369

1144

1.67

16.96

2.4

2.1

1207.56

1264.11

e6/l

0.24

322

1009

IBD patients in KELA-register

199

1037

1.93

16.96

2.0

2.6

1147.74

1233.35

e6/l

0.64

172

885

Genitourinary diseases

441

1391

1.60

16.95

3.0

2.4

1251.49

1198.81

e6/l

0.52

380

1183

Atopic dermatitis, strict definition with reimbursement

255

1378

1.79

16.90

2.6

1346.60

1295.56

e6/l

0.41

214

1151

Migraine with aura

203

1066

1.92

16.86

2.1

2.5

1831.91

1221.42

e6/l

0.67

177

901

Papilloedema, unspecified

5.02

16.73

2.8

2.5

1176.03

1425.34

e6/l

0.73

Other diseases of blood and blood-forming organs

210

3.19

16.71

1.9

2.3

1298.63

1215.69

e6/l

0.22

190

Other endocrine disorders

304

2.78

16.66

4.6

3.0

1493.57

1451.17

e6/l

0.11

226

Other diseases of intestine

126

557

2.28

16.63

2.3

2.4

1141.88

1164.82

e6/l

0.11

105

500

Other chronic obstructive pulmonary disease

282

1333

1.74

16.59

1.8

2.4

1224.35

1068.33

e6/l

2.24

253

1204

Any mental disorder

795

2842

1.40

16.52

2.8

2.3

1284.42

1179.70

e6/l

1.39

679

2481

Chronic gastritis

185

950

1.96

16.45

2.4

2.2

1222.82

1104.42

e6/l

0.93

165

856

Ulcerative enterocolitis

4.59

16.42

1.8

2.3

1345.94

1213.64

e6/l

0.29

Abnormal weight loss

367

2.60

16.36

2.3

2.4

1321.06

1194.65

e6/l

0.52

316

Special screening examination for other diseases and disorders

343

2.64

16.34

2.2

2.1

1431.88

1125.06

e6/l

2.11

310

Dorsopathies

757

2721

1.41

16.29

2.4

1295.40

1216.47

e6/l

0.89

652

2358

Pneumothorax

214

3.13

16.20

2.3

1063.23

1202.19

e6/l

0.77

194

Other gastritis (incl. Duodenitis)

164

812

2.03

16.20

2.2

2.4

1145.55

1130.41

e6/l

0.08

150

727

Other cataract

307

1353

1.69

16.16

2.4

2.3

1153.97

1115.36

e6/l

0.38

272

1208

Malignant neoplasm of bladder, including Hilmo

176

3.33

16.12

2.0

1.7

1309.70

1074.36

e6/l

0.53

157

Other or unspecified ileus, impaction or obstruction

137

636

2.17

16.02

2.2

2.4

1049.75

1152.48

e6/l

0.77

125

568

Intestinal stricture

227

1257

1.82

16.00

2.3

1039.36

1160.04

e6/l

1.57

208

1105

Other disorders of bone

165

823

2.02

15.99

2.8

2.6

1447.99

1221.14

e6/l

2.71

148

714

Disorders of choroid and retina

566

2706

1.47

15.96

2.2

2.5

1119.23

1185.59

e6/l

0.70

505

2396

COPD-related respiratory insufficiency

372

2.55

15.89

1.6

2.0

1320.30

1074.74

e6/l

1.57

333

Nonpyogenic thrombosis of intracranial venous system

7.26

15.88

2.5

2.1

1046.89

1117.48

e6/l

0.13

Raynaud syndrome

350

2.61

15.80

1.8

2.3

1008.41

1284.63

e6/l

2.61

306

Fissure and fistula of anal and rectal regions

186

973

1.93

15.70

2.3

2.4

1193.36

1200.52

e6/l

0.04

160

856

Voice disturbances

212

1160

1.84

15.57

1.9

2.4

1185.40

1205.98

e6/l

0.12

181

1020

Other intervertebral disc disorders

571

2330

1.47

15.49

2.3

2.4

1281.43

1196.77

e6/l

0.84

507

2051

Chronic laryngitis and laryngotracheitis

116

511

2.29

15.48

1.8

2.6

1348.36

1101.76

e6/l

3.06

108

455

Postmenopausal osteoporosis with pathological fracture

145

3.57

15.43

2.6

1.5

1003.40

1020.38

e6/l

0.05

131

Dermatophytosis

118

525

2.27

15.39

2.3

2.7

1116.29

1186.10

e6/l

0.47

107

465

Other symptoms and signs involving the circulatory and respiratory systems

221

3.03

15.35

2.2

2.5

1103.79

1135.41

e6/l

0.12

187

Suggestive for eosinophilic asthma

332

2.63

15.33

1.8

2.5

1380.82

1140.45

e6/l

1.54

300

Inflammatory bowel disease, strict (require KELA)

199

1077

1.86

15.17

2.0

2.6

1147.74

1247.08

e6/l

0.80

172

919

Acute laryngitis and tracheitis

109

465

2.33

15.07

3.1

2.6

1312.37

1320.02

e6/l

0.03

376

Gout, idiopatic and unspecified

175

910

1.94

15.06

2.4

2.2

1010.74

1069.22

e6/l

0.44

154

831

Heart failure and bmi 25plus

243

914

1.78

15.00

2.2

2.4

938.59

1171.13

e6/l

4.87

219

836

Varicella [chickenpox]

188

3.20

14.99

2.4

2.8

1203.37

1243.53

e6/l

0.11

162

Ulcer of lower limb, not elsewhere classified

112

494

2.29

14.91

2.1

2.2

1026.94

1064.46

e6/l

0.18

446

Rheumatism, unspecified

107

464

2.33

14.83

1.6

2.4

1401.75

1143.47

e6/l

2.64

410

Gout, unspecified

145

710

2.06

14.82

2.4

2.2

993.22

1085.42

e6/l

0.78

129

647

Crohn's disease of large intestine

174

3.28

14.81

1.9

2.7

1023.53

1286.23

e6/l

1.35

153

GI-bleeding

221

1244

1.79

14.77

2.2

2.4

1075.34

1119.65

e6/l

0.33

196

1097

Dentofacial anomalies [including malocclusion]

540

2916

1.45

14.75

2.3

2.4

1324.50

1226.09

e6/l

1.60

478

2509

Phlebitis and thrombophlebitis (not including DVT)

174

910

1.93

14.74

2.2

2.4

1204.36

1197.15

e6/l

0.02

149

815

Other specified and unspecified retinal disorders

108

3.98

14.73

2.9

2.0

1106.67

1242.99

e6/l

0.44

100

Benzodiazepine use

728

3562

1.38

14.68

2.5

2.4

1285.09

1201.20

e6/l

1.18

642

3116

Heart failure and coronary heart disease

285

1189

1.69

14.65

2.0

2.3

921.25

1085.20

e6/l

3.49

261

1065

Other ulcerative colitis

196

3.11

14.60

1.7

2.6

1318.57

1304.57

e6/l

0.03

175

Deforming dorsopathies

213

1191

1.80

14.57

2.0

2.6

1189.04

1181.33

e6/l

0.04

192

1058

Acute bronchiolitis

321

2.55

14.55

3.4

1307.09

1346.25

e6/l

0.12

228

Other viral infections characterized by skin and mucous membrane lesions, not elsewhere classified, including avohilmo

376

2.47

14.53

2.7

3.2

1534.65

1428.21

e6/l

0.47

289

Other obstetric conditions, not elsewhere classified

256

932

1.74

14.48

2.2

2.4

1434.82

1373.57

e6/l

0.55

222

783

Depression or dysthymia

484

1769

1.50

14.47

2.7

2.3

1267.55

1168.59

e6/l

0.79

420

1571

Golimumab

128

3.68

14.45

1.5

3.0

1293.92

1290.36

e6/l

0.01

113

Bronchitis, not specified as acute or chronic

290

2.69

14.43

2.4

2.5

1291.52

1148.37

e6/l

0.75

250

Hypersensitivity pneumonitis due to organic dust

6.17

14.43

2.0

902.88

1098.22

e6/l

0.46

All anxiety disorders

465

2432

1.49

14.34

2.6

2.5

1430.57

1204.15

e6/l

6.79

403

2095

Conjunctivitis (acute, non atopic), including avohilmo

743

3267

1.38

14.31

2.6

2.4

1365.14

1179.41

e6/l

0.75

645

2864

Sciatica+with lumbago

366

2086

1.56

14.29

2.3

2.4

1325.99

1193.34

e6/l

1.35

321

1844

Hypermobility syndrome

183

3.17

14.29

2.0

2.9

1578.12

1306.84

e6/l

0.99

159

Diseases of salivary glands

246

1444

1.71

14.24

2.3

2.4

1304.72

1209.06

e6/l

0.69

206

1266

Fitting and adjustment of other devices

216

1070

1.79

14.19

2.4

2.5

1195.96

1124.67

e6/l

0.53

208

956

Osteomyelitis

221

2.94

14.15

1.9

2.3

1124.61

1157.31

e6/l

0.10

200

Percutaneous Coronary Intervention

551

2324

1.45

14.07

2.0

2.6

1150.01

1218.65

e6/l

0.56

486

2038

Other maternal diseases classifiable elsewhere but complicating pregnancy, childbirth and the puerperium

248

901

1.74

14.05

2.1

2.4

1428.33

1378.51

e6/l

0.41

215

757

Juvenile arthritis (FINNGEN)

170

3.24

14.00

2.1

3.8

1335.80

1307.81

e6/l

0.08

148

Malignant neoplasm of endocrine gland, including Hilmo

201

3.02

13.96

3.1

2.2

1224.52

1224.77

e6/l

0.00

176

Other and unspecified haemorrhagic conditions

6.20

13.95

3.4

2.4

840.53

1093.79

e6/l

0.72

Pyothorax

136

3.52

13.92

1.8

2.1

1025.45

1164.68

e6/l

0.51

123

Other diseases of the digestive system

219

1253

1.76

13.89

2.2

2.4

1073.45

1127.65

e6/l

0.43

194

1102

Malignant neoplasm of endocrine gland

176

3.16

13.84

2.9

2.2

1206.94

1246.46

e6/l

0.12

153

Allergic rhinitis

267

1593

1.66

13.84

2.2

2.8

1430.37

1272.90

e6/l

2.37

224

1331

Faecal incontinence

251

2.78

13.83

2.5

2.1

1067.82

1120.56

e6/l

0.22

224

Cerebral palsy and other paralytic syndromes

103

454

2.29

13.80

2.8

2.6

1384.30

1255.37

e6/l

0.58

389

Need for other prophylactic measures

220

2.91

13.68

3.6

2.8

3518.50

1277.76

e6/l

0.45

193

Disorders of refraction and accommodation

246

1457

1.69

13.60

3.2

2.7

1364.70

1282.12

e6/l

0.64

205

1219

Vascular disorders of the intestines

168

3.19

13.55

1.4

1.9

987.74

1048.40

e6/l

0.22

151

Diverticular disease of intestine

456

1914

1.49

13.54

2.1

2.4

1126.19

1130.52

e6/l

0.03

405

1714

Other arrhythmias

442

2226

1.49

13.53

2.1

2.6

1125.48

1263.29

e6/l

1.61

384

1949

Emergency coronary revascularization (for ACS)

583

2485

1.42

13.52

2.0

2.6

1129.73

1201.44

e6/l

0.64

517

2188

Chronic hepatitis, not elsewhere classified

106

3.86

13.48

1.5

2.0

1240.55

1295.26

e6/l

0.12

Visual field defects

289

2.63

13.48

2.0

2.3

1235.13

1154.78

e6/l

0.39

259

Diseases of arteries, arterioles and capillaries

445

2206

1.48

13.44

2.0

2.4

1081.50

1165.79

e6/l

0.67

388

1982

Ischemic heart diseases

580

2438

1.42

13.41

2.0

2.6

1140.61

1219.42

e6/l

0.71

518

2138

Migraine with aura and triptan purchases

142

718

1.99

13.35

2.1

2.6

1332.63

1313.32

e6/l

0.11

123

596

Coronary revascularization (ANGIO or CABG)

547

2326

1.43

13.32

2.1

2.6

1151.61

1219.32

e6/l

0.55

484

2039

Recurrent or chronic depression

297

1273

1.63

13.29

2.6

2.4

1402.82

1137.81

e6/l

5.31

251

1120

Missing teeth due to accident, extraction or parodontitis

428

2587

1.48

13.26

2.7

2.3

1182.72

1159.36

e6/l

0.17

379

2310

Tonsillectomy and adenotomy

457

2164

1.48

13.26

2.6

1477.79

1269.24

e6/l

5.35

391

1814

Fibromyalgia

345

2.46

13.22

1.9

2.4

1465.25

1237.59

e6/l

1.49

299

Myositis

4.39

13.19

1.5

2.1

1014.68

1100.21

e6/l

0.25

Polymyalgia rheumatica

394

2.36

13.17

1.9

2.0

1149.57

1063.03

e6/l

0.35

352

Atrial fibrillation and flutter with reimbursement

160

517

1.96

13.15

2.3

2.9

1015.23

1114.70

e6/l

0.82

146

468

Atopic dermatitis

439

2375

1.48

13.12

2.5

1385.74

1236.07

e6/l

2.60

363

2043

Dental caries, including avohilmo

491

1718

1.47

13.11

2.5

2.2

1181.87

1169.78

e6/l

0.10

428

1488

Major coronary heart disease event

579

2456

1.41

13.10

2.0

2.6

1140.94

1212.57

e6/l

0.63

513

2163

Dependence on enabling machines and devices, not elsewhere classified

5.44

13.03

2.5

1.9

1341.78

1537.79

e6/l

0.27

Psoriasis

213

1233

1.74

13.02

2.3

2.5

1180.47

1214.94

e6/l

0.19

193

1080

Congenital malformations of the respiratory system, including avohilmo

110

3.78

12.90

2.9

3.7

1514.34

1390.04

e6/l

0.23

Sleep apnoea

662

3040

1.38

12.89

2.0

2.5

1263.67

1179.43

e6/l

0.98

595

2654

Other keratitis

103

468

2.22

12.87

3.0

2.4

1379.28

1200.67

e6/l

1.09

401

Psoriasis vulgaris

147

763

1.94

12.83

2.4

1111.81

1207.99

e6/l

0.63

132

670

Myeloproliferative diseases (CML excluded)

239

2.76

12.82

3.5

2.1

2501.05

1171.96

e6/l

0.41

213

Any mental disorder, or suicide (or attempt), or psychic disorders complicating pregnancy, partum or puerperium or nerve system disorders

226

1336

1.70

12.81

2.3

2.5

1440.46

1273.97

e6/l

2.33

189

1151

Other diseases of hard tissues of teeth

346

1143

1.57

12.79

2.4

2.1

1188.46

1263.91

e6/l

0.33

293

1008

Focal epilepsy, strict definition

163

876

1.87

12.78

2.3

2.7

1125.40

1198.92

e6/l

0.43

141

746

Disorders of tooth development and eruption

127

504

2.06

12.70

2.7

2.3

1335.43

1257.56

e6/l

0.43

104

439

Seborrhoeic dermatitis

346

2.42

12.66

2.6

2.5

1306.35

1164.44

e6/l

0.51

306

Spondylopathies (FG)

107

497

2.17

12.64

1.7

2.7

1219.65

1238.38

e6/l

0.08

439

Conductive and sensorineural hearing loss

536

2516

1.42

12.58

2.4

2.5

1139.20

1178.49

e6/l

0.32

489

2220

Melanocytic naevi

239

1442

1.67

12.55

2.3

2.5

1175.68

1229.19

e6/l

0.49

208

1253

Personal history of malignant neoplasm

282

2.58

12.54

2.5

2.2

1290.58

1220.22

e6/l

0.30

242

Diseases of inner ear

360

2283

1.51

12.51

2.1

2.3

1229.69

1176.92

e6/l

0.33

326

2013

Varicella [chickenpox], including avohilmo

254

2.68

12.49

3.1

2.9

1168.66

1258.80

e6/l

0.31

212

Focal epilepsy

175

969

1.82

12.48

2.4

2.7

1123.00

1208.41

e6/l

0.56

151

825

Anxiety (asthma-related co-morbidities)

456

2398

1.45

12.36

2.6

2.4

1431.82

1191.00

e6/l

7.44

397

2092

Disorders of psychological development

128

593

2.02

12.34

3.5

2.7

1404.33

1415.09

e6/l

0.03

103

468

Symptoms and signs involving cognition, perception, emotional state and behaviour

691

3419

1.35

12.28

2.3

2.4

1281.00

1205.89

e6/l

0.93

602

2996

Other anxiety disorders

348

1950

1.52

12.28

2.4

2.5

1472.96

1215.62

e6/l

6.66

298

1671

Ascites

228

2.75

12.24

2.0

2.3

876.49

1051.14

e6/l

0.97

200

Early onset COPD

161

875

1.85

12.22

1.8

2.6

1328.16

1130.39

e6/l

1.82

140

780

Diseases of pulp and periapical tissues and dental caries

431

1494

1.48

12.22

2.4

2.2

1166.83

1176.63

e6/l

0.08

370

1289

Need for immunization against other single viral diseases

4.73

12.21

2.1

1518.57

1114.70

e6/l

1.20

Congenital malformations of the respiratory system

105

3.77

12.20

2.8

3.8

1589.83

1405.19

e6/l

0.37

Meningitis, viral

13.06

12.19

1.6

1.4

1541.13

1481.92

e6/l

0.09

Speech and linguistic disorders

106

477

2.16

12.16

4.1

2.8

1552.65

1428.10

e6/l

0.43

366

Deviated nasal septum

229

1377

1.67

12.13

2.0

2.5

1318.92

1090.01

e6/l

2.61

207

1230

Impetigo

202

2.87

12.10

2.7

2.9

1432.46

1373.71

e6/l

0.16

166

Gout, strict definition

128

647

1.99

12.09

2.3

2.2

1020.41

1078.66

e6/l

0.33

109

588

Infections with a predominantly sexual mode of transmission

235

1424

1.66

12.04

2.5

2.4

1434.63

1284.99

e6/l

1.08

202

1214

Inflammatory diseases of female pelvic organs

424

1984

1.47

12.02

2.2

2.3

1366.52

1291.13

e6/l

0.57

372

1715

Juvenile rheumatoid arthirtis

4.39

12.01

2.4

2.7

1187.52

1302.70

e6/l

0.32

Other and unspecified visual disturbances

386

2.30

11.99

2.3

2.4

1234.61

1199.15

e6/l

0.16

338

Paroxysmal tachycardia

160

718

1.86

11.98

2.0

3.0

1112.56

1225.60

e6/l

1.01

136

630

Other peripheral vascular diseases

290

2.51

11.87

1.8

2.5

989.22

1226.08

e6/l

1.75

261

Other noninfective disorders of lymphatic vessels and lymph nodes

116

3.51

11.85

2.5

2.1

895.69

1204.93

e6/l

1.63

103

Fracture of lumbar spine and pelvis

152

818

1.86

11.80

2.2

2.3

1019.40

1147.11

e6/l

1.24

137

729

Allergic purpura

3.84

11.79

1.9

2.5

994.55

1282.64

e6/l

0.94

Convalescence

136

3.28

11.78

1.8

2.5

1126.67

1202.10

e6/l

0.23

123

Bell's palsy

453

2.18

11.77

2.8

2.4

1257.21

1151.15

e6/l

0.56

399

Cystitis

575

2470

1.39

11.74

2.7

2.3

1248.53

1186.63

e6/l

0.89

486

2172

Abnormal involuntary movements

107

514

2.10

11.65

2.4

1471.54

1151.05

e6/l

1.64

447

Pyogenic arthritis

212

2.77

11.60

1.9

2.5

1003.98

1137.20

e6/l

0.59

189

Benign neoplasm of other and ill-defined parts of digestive system

131

679

1.94

11.54

2.0

2.3

1169.61

1164.52

e6/l

0.02

109

609

In situ neoplasms

265

1677

1.59

11.50

2.3

1195.49

1167.74

e6/l

0.16

234

1488

Endocarditis

3.90

11.40

1.9

3.1

927.32

1247.47

e6/l

1.04

Invasive ventilation

284

2.50

11.39

2.3

2.5

1336.44

1226.91

e6/l

0.34

246

Disorders of vestibular function (Vertigo)

305

1943

1.53

11.38

2.2

2.3

1262.33

1197.72

e6/l

0.36

275

1715

Gingivitis and periodontal diseases

703

2712

1.34

11.32

2.5

2.3

1271.04

1207.26

e6/l

0.64

607

2365

Injuries to the abdomen, lower back, lumbar spine and pelvis

285

1814

1.55

11.30

2.3

2.5

1478.57

1196.06

e6/l

0.38

247

1592

Thyroiditis, ILD-related definition

371

2.28

11.28

1.9

2.3

1165.97

1320.24

e6/l

0.81

307

Pruritus

404

2.22

11.20

2.4

2.2

1339.14

1166.65

e6/l

1.36

348

Unspecified chronic bronchitis

3.75

11.15

1.8

2.1

1240.48

1163.35

e6/l

0.18

Diseases of tongue

167

2.97

11.14

1.7

2.4

1066.83

1032.16

e6/l

0.11

147

Focal epilepsy, mode (most common among epilepsy diagnosis)

151

829

1.83

11.14

2.4

2.7

1130.87

1189.19

e6/l

0.30

132

702

Other disorders of conjunctiva

108

530

2.06

11.12

2.4

1175.04

1140.36

e6/l

0.16

473

Other disorders starting during childhood or adolecense, excluding more controls

228

2.64

11.12

4.6

2.8

1554.15

1394.26

e6/l

0.46

165

Triptan medication for migraine, min. 3 purchases

408

2109

1.45

11.11

2.2

2.4

1378.95

1259.62

e6/l

2.13

350

1820

Hydronephrosis

374

2.27

11.07

2.4

881.91

1095.92

e6/l

2.24

332

Paraplegia, diplegia of upper limbs

4.46

11.04

3.6

1.9

1043.18

1164.88

e6/l

0.27

Caries of dentine, including avohilmo

532

1952

1.40

10.99

2.5

2.4

1199.81

1180.65

e6/l

0.18

463

1672

Acute nasopharyngitis (common cold)

398

2.21

10.94

2.3

2.6

1256.46

1183.86

e6/l

0.38

349

Non-selective monoamine reuptake inhibitors

244

1469

1.60

10.93

1.9

2.3

1378.93

1193.26

e6/l

1.26

213

1322

Other diseases of stomach and duodenum

191

2.81

10.91

2.2

2.4

1202.67

1084.46

e6/l

0.38

170

Other juvenile arthritis

170

2.94

10.85

2.2

3.7

1365.76

1248.90

e6/l

0.40

146

Malignant melanoma, including Hilmo

358

2.28

10.85

2.6

2.0

1044.48

1131.70

e6/l

0.57

317

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly

152

818

1.82

10.81

2.3

2.9

1209.77

1302.36

e6/l

0.54

124

671

Specific development disorders of scholastic skills

262

2.52

10.79

5.7

2.9

1565.85

1409.66

e6/l

0.46

201

Psychiatric diseases

685

2572

1.34

10.74

2.7

2.4

1263.42

1174.81

e6/l

0.94

592

2247

Benign neoplasm of colon, rectum, anus and anal canal

408

2411

1.43

10.72

2.3

1096.44

1153.25

e6/l

0.46

363

2177

Reactive arthropathies, FINNGEN

233

2.61

10.70

2.1

2.8

1264.22

1214.02

e6/l

0.20

210

Lumbar disc prolapse

427

2222

1.43

10.68

2.4

1342.01

1197.05

e6/l

1.61

385

1967

Sensorineural hearing loss

492

2355

1.40

10.68

2.3

2.5

1146.63

1166.05

e6/l

0.13

450

2092

Other disorders of bladder

432

2.15

10.67

2.4

2.3

1300.09

1105.17

e6/l

1.00

393

Chronic suppurative otitis media, including avohilmo

319

2.35

10.57

2.3

2.7

1384.95

1254.32

e6/l

0.55

264

malignant neoplasm of male genital organs, including Hilmo

132

410

1.94

10.57

2.6

2.2

1019.83

1081.99

e6/l

0.26

120

372

STROKE

371

1710

1.47

10.50

2.3

2.6

1170.88

1179.67

e6/l

0.06

328

1517

Other disorders of central nervous system

5.59

10.48

3.3

2.3

1389.67

1259.20

e6/l

0.20

Cardiomyopathy

114

583

1.97

10.45

2.1

2.7

1049.77

1137.63

e6/l

0.43

522

Migraine without aura and triptan purchases

139

760

1.84

10.44

2.2

2.5

1426.16

1316.99

e6/l

0.74

112

627

Malignant neoplasm of breast, ER-negative, including Hilmo

436

2.09

10.43

2.4

2.1

1072.97

1217.90

e6/l

1.12

377

DVT of lower extremities

127

675

1.89

10.41

2.2

2.4

1147.03

1176.29

e6/l

0.13

112

606

Strabismus

217

1340

1.62

10.39

3.0

2.7

1239.35

1275.36

e6/l

0.29

190

1127

Malnutrition

3.74

10.33

3.6

3.1

1401.15

1152.51

e6/l

0.44

Type 2 diabetes, wide definition

524

2408

1.38

10.32

2.1

2.5

1224.73

1186.19

e6/l

0.26

470

2131

COPD, early/later onset

282

1551

1.53

10.26

1.8

2.3

1224.35

1075.80

e6/l

2.11

253

1398

COPD, hospital admissions

279

1537

1.53

10.26

1.8

2.3

1224.17

1077.90

e6/l

2.04

252

1386

Oesophageal varices

138

3.10

10.24

1.5

2.5

778.17

1172.37

e6/l

2.43

118

Rosacea

104

520

2.02

10.22

2.4

1294.20

1256.54

e6/l

0.17

452

Other diseases of anus and rectum

195

1176

1.66

10.20

2.2

2.4

1150.13

1152.52

e6/l

0.01

170

1044

Pyoderma gangrenosum

9.64

10.18

1.8

1.7

908.08

1353.00

e6/l

1.07

Nummular dermatitis

269

2.44

10.17

3.3

2.6

1269.29

1111.32

e6/l

0.63

240

Herpesviral keratitis and keratoconjunctivitis

123

3.22

10.16

2.8

2.1

1191.81

1228.00

e6/l

0.10

113

Malignant melanoma

306

2.33

10.11

2.8

1.9

963.56

1142.87

e6/l

1.52

273

Paralytic strabismus

240

2.53

10.10

2.7

2.4

1243.67

1172.15

e6/l

0.31

213

Other inflammation of eyelid

110

564

1.97

10.07

2.8

2.4

1116.10

1151.96

e6/l

0.21

101

486

Other/unspecified reactive arthropathies

229

2.57

10.04

2.1

2.5

1269.58

1247.72

e6/l

0.07

202

Unspecified haematuria

278

1485

1.53

10.04

2.4

2.3

1157.71

1124.44

e6/l

0.20

243

1335

Cerebral cysts

206

2.66

10.02

2.3

2.6

1323.52

1263.35

e6/l

0.17

181

Psoriatic and enteropathic arthropathies

404

2.15

9.99

1.7

2.8

1181.12

1225.94

e6/l

0.15

362

Crohn disease (strict definition, require KELA)

254

2.47

9.94

1.8

2.9

916.14

1313.07

e6/l

3.46

221

Hyperlipidaemia, other/unspecified

243

1399

1.57

9.92

2.1

2.4

1107.36

1081.98

e6/l

0.18

224

1267

Colonic or urogenital fistula

193

1175

1.65

9.92

2.3

2.4

1204.04

1193.73

e6/l

0.06

166

1032

Crohn disease (strict definition, require KELA, min 2 HDR)

250

2.47

9.78

1.8

2.9

916.14

1311.49

e6/l

3.43

219

Hernia

635

3198

1.32

9.77

2.4

1357.85

1184.99

e6/l

0.57

562

2778

Conduction disorders

186

896

1.67

9.67

2.0

2.6

995.23

1183.21

e6/l

2.77

168

795

Other CVD

130

714

1.83

9.64

1.7

2.2

1123.28

1088.98

e6/l

0.15

116

648

Congenital malformations and deformations of the musculoskeletal system

100

502

2.01

9.62

2.3

2.9

1485.74

1392.21

e6/l

0.45

396

Benign neoplasm: Colon

342

2225

1.45

9.60

2.4

2.3

1110.31

1142.66

e6/l

0.20

303

2011

Hypothyroidism, other/unspecified

598

2962

1.33

9.59

2.3

2.4

1192.37

1219.25

e6/l

0.23

519

2592

Adverse effects, not elsewhere classified

162

951

1.72

9.58

2.1

2.6

1416.54

1240.73

e6/l

1.61

134

801

Dizziness and giddiness

511

2938

1.36

9.56

2.3

2.4

1288.32

1186.51

e6/l

1.25

456

2586

Other follicular disorders

302

2.31

9.56

2.7

2.8

1316.15

1277.84

e6/l

0.12

265

Cholelithiasis, broad definition with cholecystitis

566

2819

1.34

9.53

2.4

1164.89

1200.62

e6/l

0.31

504

2496

Other diseases of liver

137

768

1.80

9.53

2.4

2.6

1244.97

1183.09

e6/l

0.36

115

671

Allergic urticaria

335

2.23

9.46

2.7

2.9

1408.05

1308.26

e6/l

0.38

285

Congenital malformations of trachea and bronchus

4.89

9.42

2.7

4.1

1779.31

1285.00

e6/l

0.80

Vertebral, anorectal, cardiavascular, thracheoesophagial, renal and limb anomaly, including avohilmo

153

863

1.73

9.38

2.3

2.9

1221.76

1281.02

e6/l

0.30

125

710

Tuberculosis, IBD comorbidity

184

2.69

9.38

1.9

2.0

1377.07

1027.34

e6/l

1.02

164

Irregular menses

330

1705

1.46

9.36

2.8

2.3

1355.22

1271.02

e6/l

1.13

291

1465

Diseases of pulp and periapical tissues, including avohilmo

723

2886

1.30

9.35

2.4

2.5

1250.47

1235.58

e6/l

0.12

631

2497

Developmental endpoint to exclude non autoimmune-cases from E4_HYTHY_AI_STRICT

244

1595

1.54

9.30

2.4

2.6

1260.86

1214.36

e6/l

0.27

205

1383

Other local infections of skin and subcutaneous tissue

417

2.08

9.24

3.8

2.7

1207.82

1170.22

e6/l

0.14

360

Other congenital malformations

444

2.05

9.24

3.9

3.0

1352.38

1385.12

e6/l

0.11

354

Haemorrhoids and perianal venous thrombosis

210

1319

1.59

9.23

2.1

2.3

1126.06

1135.37

e6/l

0.06

182

1174

Chronic myeloid leukaemia, including Hilmo

11.92

9.16

4.4

2.3

1129.06

1166.29

e6/l

0.05

Other retinal disorders

406

2213

1.40

9.14

2.1

2.4

1086.73

1187.68

e6/l

0.99

365

1967

Cholelithiasis

541

2765

1.34

9.13

2.3

2.4

1167.38

1202.52

e6/l

0.29

481

2447

Hypothyreosis and Thyroxine purchase for inclusion criteria

614

3065

1.31

9.10

2.3

2.4

1192.33

1222.31

e6/l

0.27

532

2682

Neuralgia and neuritis, unspecified

182

2.67

9.05

1.8

2.4

1477.73

1149.84

e6/l

1.48

167

Coeliac disease

100

516

1.96

9.05

2.7

1189.57

1216.62

e6/l

0.12

438

Malignant neoplasm of breast, HER-negative

402

2.06

9.05

2.4

2.1

1076.09

1224.51

e6/l

1.04

351

Emphysema

223

2.49

9.03

1.7

2.2

1039.28

1038.05

e6/l

0.00

192

Vulvovaginal ulceration/inflammation in other diseases

272

2.34

9.03

2.5

2.4

1352.74

1272.80

e6/l

0.26

231

Disorders of synovium and tendon

362

2171

1.42

9.03

2.5

2.4

1335.76

1197.13

e6/l

1.21

323

1901

Total colectomy

138

2.94

9.00

2.2

2.6

1402.09

1299.91

e6/l

0.22

126

Total colectomy operation

138

2.94

9.00

2.2

2.6

1402.09

1299.91

e6/l

0.22

126

Unspecified fall

360

2507

1.41

8.99

2.2

2.5

1236.03

1195.59

e6/l

0.40

312

2167

Allergic contact dermatitis

100

517

1.95

8.99

1.7

2.5

1273.84

1239.04

e6/l

0.16

452

Cholangitis (primary sclerosing, PSC)

206

2.55

8.97

1.9

2.6

986.32

1206.78

e6/l

1.14

179

Other predominantly sexually transmitted diseases, not elsewhere classified

133

754

1.78

8.94

2.5

2.4

1514.89

1307.25

e6/l

0.86

116

634

Pollen allergy

174

1047

1.65

8.91

2.4

2.9

1463.97

1341.39

e6/l

1.10

143

852

Other chronic obstructive pulmonary disease, including avohilmo

333

1909

1.44

8.88

1.8

2.4

1212.70

1089.84

e6/l

1.86

300

1723

Spinal stenosis

308

1558

1.46

8.84

2.0

2.3

1216.99

1149.56

e6/l

0.34

278

1411

Fibrosis and cirrhosis of liver

288

2.28

8.79

1.9

2.4

822.54

1142.27

e6/l

3.04

259

External causes of morbidity and mortality

459

1676

1.38

8.77

2.3

2.4

1286.38

1190.30

e6/l

1.27

394

1443

Abnormalities of gait and mobility

453

2.00

8.76

2.6

2.2

1264.76

1134.46

e6/l

0.76

396

Hypotension

108

578

1.88

8.74

1.7

2.1

1177.88

1100.08

e6/l

0.35

523

Pain associated with micturition

467

1.99

8.74

3.4

2.3

1310.68

1177.81

e6/l

1.02

406

Crohn's disease patients in KELA-register (KELA code 209, or 208 with ICD K50)

270

2.32

8.73

1.8

2.9

916.14

1312.18

e6/l

3.49

232

UC patients in KELA-register ( KELA 208 prior to 1994, or ICD K51)

138

798

1.74

8.67

2.0

2.6

1264.01

1218.75

e6/l

0.21

116

690

Colorectal cancer, including Hilmo

105

518

1.90

8.67

2.0

1.9

1127.67

1093.82

e6/l

0.10

462

Tuberculosis, wide, including avohilmo

198

2.55

8.64

1.9

2.1

1374.58

1082.79

e6/l

0.79

175

Delayed milestone in childhood

200

2.54

8.61

3.6

4.3

1544.07

1558.55

e6/l

0.03

137

Alzheimer disease, including avohilmo

943

0.47

8.61

2.4

1.9

914.30

1049.32

e6/l

0.92

856

malignant neoplasm of female genital organs, including Hilmo

356

2.10

8.58

2.1

1078.42

1223.02

e6/l

0.83

310

Other disorders of nervous system

235

2.41

8.57

1.9

2.3

1226.98

1163.93

e6/l

0.20

214

Parapsoriasis

4.13

8.57

1.8

2.3

1509.41

1283.12

e6/l

0.28

Disorders of vitreous body and globe

324

2151

1.43

8.57

2.3

1205.66

1165.92

e6/l

0.27

290

1927

Tuberculosis

153

2.77

8.55

1.7

2.0

1238.25

1089.87

e6/l

0.27

135

Scleritis and episcleritis

230

2.42

8.49

2.5

2.4

1341.70

1256.67

e6/l

0.26

201

COPD related to multimorbidity

233

1295

1.53

8.46

1.7

2.3

1170.82

1062.55

e6/l

1.18

209

1172

Otalgia

358

2.12

8.44

3.2

2.6

1300.63

1205.07

e6/l

0.39

304

Other and unspecified local infections of skin and subcutaneous tissue

392

2.06

8.40

3.9

2.7

1219.06

1185.40

e6/l

0.11

339

Tuberculosis, wide

195

2.54

8.39

1.9

2.1

1377.07

1078.25

e6/l

0.79

172

Disorders of vitreous body

316

2110

1.43

8.39

2.3

1217.98

1167.82

e6/l

0.35

283

1888

Other and unspecified effects of external causes

210

1361

1.55

8.39

2.2

2.7

1369.74

1249.18

e6/l

1.10

176

1150

Malignant neoplasm of prostate, including Hilmo

117

372

1.86

8.37

2.5

2.1

1022.87

1059.15

e6/l

0.12

106

338

Ulcerative colitis (strict definition, require KELA, min 2 HDR)

126

718

1.77

8.36

2.0

2.4

1261.94

1217.41

e6/l

0.20

107

620

Atopic dermatitis, strict definition

239

1559

1.51

8.31

2.6

2.7

1365.37

1322.05

e6/l

0.32

201

1297

Motor disorders, excluding more controls

105

3.15

8.28

3.6

3.0

1701.77

1464.26

e6/l

0.38

Sleep apnoea, including avohilmo

667

3146

1.28

8.25

2.0

2.5

1283.27

1187.10

e6/l

1.22

596

2750

Colectomy operation

112

619

1.82

8.23

2.2

2.4

1279.91

1102.75

e6/l

0.69

551

Other bursopathies

492

1.92

8.19

2.2

2.5

1104.13

1124.30

e6/l

0.10

443

Crossbite

395

2.01

8.15

3.2

1444.60

1367.31

e6/l

0.24

316

Ulcerative colitis (strict definition, require KELA)

129

746

1.74

8.14

2.0

2.5

1261.14

1216.35

e6/l

0.20

109

644

Pacemaker

210

1271

1.54

8.11

1.9

2.2

984.58

1090.03

e6/l

1.13

190

1145

Bullous disorders

175

2.60

8.10

1.9

2.1

1015.26

1175.54

e6/l

0.81

156

Smoking dependency

351

2.10

8.09

2.5

1526.54

1202.82

e6/l

2.16

317

Mental and behavioural disorders due to tobacco

351

2.10

8.09

2.5

1526.54

1189.19

e6/l

2.31

315

Other and unspecified rosacea

352

2.09

8.03

2.3

2.5

1348.30

1231.17

e6/l

0.58

315

Chronic suppurative otitis media

230

2.37

8.02

2.5

2.4

1412.00

1254.93

e6/l

0.52

194

Other Crohn's disease

249

2.31

8.00

2.4

2.8

1045.18

1283.79

e6/l

1.34

216

Other disorders of eyelid

261

1684

1.47

7.98

2.4

2.2

1179.98

1159.01

e6/l

0.09

228

1501

Alopecia areata

3.25

7.98

2.5

3.0

1155.96

1260.05

e6/l

0.28

Otitis externa, unspecified

497

1.91

7.97

2.7

1393.79

1235.60

e6/l

0.88

422

Persons encountering health services in circumstances related to reproduction

420

2076

1.36

7.93

2.8

2.7

1370.48

1210.59

e6/l

2.83

354

1790

Reactive arthropathies

314

2.15

7.93

2.1

2.5

1307.59

1177.70

e6/l

0.65

271

malignant neoplasm of male genital organs

120

401

1.81

7.90

2.6

2.2

1033.38

1088.43

e6/l

0.21

110

365

Seronegative juvenile rheumatoid arthritis

3.46

7.86

2.6

3.9

1179.95

1488.00

e6/l

0.96

Sleep disorders (combined)

747

3097

1.26

7.84

2.1

2.5

1294.64

1189.11

e6/l

1.51

655

2710

Disease of hard tissues of teeth, NOS

307

1116

1.44

7.84

2.3

2.1

1260.21

1243.50

e6/l

0.06

266

989

Clefts and syndromes for tooth agenesis exclusion, including avohilmo

209

2.44

7.77

3.8

3.6

1353.35

1371.31

e6/l

0.04

159

Vitamin deficiency

156

2.66

7.73

2.6

2.5

1283.66

1215.72

e6/l

0.14

143

Vitamin deficiency, wide

156

2.66

7.73

2.6

2.5

1283.66

1215.72

e6/l

0.14

143

Anomalies of dental arch relationship, including avohilmo

161

903

1.62

7.69

3.1

2.6

1203.50

1330.90

e6/l

1.12

143

756

Lichen simplex chronicus and prurigo

186

2.50

7.66

2.0

2.1

1206.72

1096.15

e6/l

0.44

168

Other congenital malformations, not elsewhere classified

4.28

7.65

2.3

5.0

1614.27

1228.28

e6/l

0.60

Disorders of the thyroid gland

627

3185

1.28

7.65

2.4

1207.92

1215.39

e6/l

0.06

543

2792

Infections with a predominantly sexual mode of transmission, including avohilmo

285

1828

1.43

7.63

2.4

1421.64

1287.25

e6/l

1.15

241

1562

N06DA Anticholinesterases

971

0.48

7.63

2.3

1.9

1171.53

1047.16

e6/l

0.38

880

Use of anticholinesterases

971

0.48

7.63

2.3

1.9

1171.53

1047.16

e6/l

0.38

880

Short stature, not elsewhere classified

213

2.39

7.61

5.8

3.5

1694.93

1511.07

e6/l

0.47

147

Behavioural and emotional disorders with onset usually occurring in childhood and adolescence

187

1049

1.56

7.61

2.5

2.8

1503.53

1380.12

e6/l

0.81

148

851

Dermatographic urticaria

249

2.27

7.56

2.7

2.3

1553.75

1303.72

e6/l

1.10

215

Amenorrhoea

281

2.19

7.56

4.0

2.1

1243.73

1334.11

e6/l

0.48

232

Carcinoma in situ of skin of other and unspecified parts of face

230

2.32

7.56

2.6

1.9

1078.65

1033.61

e6/l

0.15

207

Nonorganic sleeping disorders, excluding more controls

141

853

1.66

7.55

2.0

2.4

1414.72

1209.48

e6/l

1.32

112

724

Malignant neoplasm of breast, HER2-negative, including Hilmo

190

778

1.57

7.52

2.2

2.1

1106.67

1262.23

e6/l

1.77

172

668

Malignant neoplasm of breast, including Hilmo

190

778

1.57

7.52

2.2

2.1

1106.67

1262.23

e6/l

1.77

172

668

Type of accident

206

1364

1.52

7.51

2.1

2.5

1750.66

1213.68

e6/l

0.61

189

1189

Post-traumatic stress disorder

342

2.06

7.46

2.4

2.5

1587.13

1304.82

e6/l

1.87

288

Other female pelvic inflammatory diseases

109

617

1.78

7.45

2.1

2.4

1391.13

1216.28

e6/l

1.43

537

Disorders of muscles

404

1.97

7.42

1.9

2.6

1172.85

1149.18

e6/l

0.09

350

Tooth eruption problems

127

725

1.70

7.41

3.5

2.9

1533.01

1354.27

e6/l

1.42

105

596

Perforation of tympanic membrane

377

2.01

7.40

2.6

2.5

1108.83

1181.16

e6/l

0.40

330

Excessive attrition of teeth

428

3196

1.33

7.37

2.3

2.5

1177.95

1218.02

e6/l

0.46

355

2788

Retinal detachments and breaks

213

1427

1.50

7.34

2.1

2.3

1150.39

1128.98

e6/l

0.16

189

1280

Other disorders of kidney and ureter

512

1.85

7.31

2.6

2.4

1186.13

1085.77

e6/l

0.35

451

Other congenital malformations, including avohilmo

113

651

1.75

7.28

3.5

2.7

1490.43

1329.24

e6/l

0.47

531

Other benign neoplasms of skin

234

1601

1.47

7.27

2.1

2.4

1605.12

1160.88

e6/l

0.54

206

1419

Hyperparathyroidism

104

578

1.79

7.27

2.3

2.2

1101.51

1142.43

e6/l

0.19

511

Other external causes of accidental injury

565

2191

1.29

7.26

2.3

2.6

1306.39

1186.93

e6/l

2.16

483

1907

Supplementary factors related to causes of morbidity and mortality classified elsewhere

219

1481

1.49

7.23

2.3

2.6

1724.03

1207.76

e6/l

0.62

200

1292

Migraine, single triptan purchase ok & required. ICD-code if available is included

519

2714

1.30

7.18

2.5

1354.87

1198.14

e6/l

4.42

446

2354

Triptan medication for migraine, single purchase ok

519

2714

1.30

7.18

2.5

1354.87

1198.14

e6/l

4.42

446

2354

Other and unspecified nerve root and plexus disorders, also in other diseases

143

881

1.63

7.16

2.1

2.5

1303.38

1179.92

e6/l

0.96

124

782

Heterophoria

348

2.03

7.14

3.5

2.7

1173.35

1327.26

e6/l

0.86

295

Abscess of anal and rectal regions

321

2.07

7.14

2.0

2.9

1113.52

1179.59

e6/l

0.23

285

Hyperkinetic disorders, excluding more controls

105

554

1.78

7.13

2.4

2.6

1548.92

1282.25

e6/l

1.53

445

Malignant neoplasm of breast, HER2-negative

183

759

1.56

7.10

2.2

2.1

1107.74

1256.10

e6/l

1.58

165

651

Ulcerative ileocolitis

129

2.75

7.04

2.2

2.5

1369.63

1283.26

e6/l

0.16

120

Ankylosing spondylitis

337

2.04

7.00

1.8

2.4

1186.15

1115.23

e6/l

0.24

301

Spondylosis

329

1870

1.38

7.00

2.2

2.4

1224.82

1160.27

e6/l

0.41

292

1666

Other predominantly sexually transmitted diseases, not elsewhere classified, including avohilmo

150

942

1.60

6.96

2.4

1519.59

1312.50

e6/l

0.98

128

802

Ankylosing spondylitis, ICD10

338

2.03

6.95

1.8

2.6

1186.15

1201.00

e6/l

0.04

303

Colorectal cancer

463

1.85

6.95

1.9

1161.93

1088.97

e6/l

0.20

410

Cardiomyopathies, Primary/intrinsic

393

1.95

6.93

2.3

2.5

923.68

1153.12

e6/l

1.67

356

Injury, poisoning and certain other consequences of external causes

374

1377

1.36

6.93

2.4

1309.87

1200.53

e6/l

1.25

316

1172

Open wound of lower leg

109

631

1.74

6.93

2.0

2.5

1130.70

1192.92

e6/l

0.31

543

Cardiomyopathy (excluding other)

415

1.92

6.88

2.4

913.02

1152.84

e6/l

1.83

372

Malignant neoplasm of breast

182

760

1.55

6.86

2.2

2.1

1113.03

1255.35

e6/l

1.48

164

652

Other bullous disorders

3.30

6.86

1.9

2.1

1121.16

1269.53

e6/l

0.38

Oral leukoplakia and other epithelial disorders of tongue and oral cavity , including avohilmo

333

2.03

6.86

1.9

2.2

1312.69

1155.56

e6/l

0.70

299

Falls/tendency to fall

748

3023

1.24

6.83

2.3

2.5

1291.36

1203.42

e6/l

1.82

644

2617

Other nutritional deficiencies

461

3243

1.30

6.80

2.1

2.5

1376.47

1192.38

e6/l

4.41

403

2823

Pain and other conditions associated with female genital organs and menstrual cycle

148

774

1.61

6.79

2.0

2.1

1398.23

1279.40

e6/l

1.03

125

667

AV-block

101

488

1.78

6.77

1.9

2.4

944.94

1114.90

e6/l

1.35

440

Accidents

560

2191

1.28

6.76

2.4

2.6

1294.20

1186.93

e6/l

1.82

478

1907

Obesity due to excess calories

330

2431

1.36

6.75

2.2

2.5

1401.81

1198.81

e6/l

4.02

299

2111

Gonarthrosis [arthrosis of knee](FG)

403

1738

1.34

6.73

2.4

2.5

1195.39

1185.02

e6/l

0.08

357

1557

Coxarthrosis [arthrosis of hip](FG)

287

1410

1.40

6.70

2.2

2.4

1116.75

1174.27

e6/l

0.51

258

1275

Other coagulation defects

263

2.15

6.66

2.5

2.4

1136.04

1257.13

e6/l

0.51

226

Short Achilles tendon (acquired)

3.14

6.61

3.4

2.3

1408.80

1183.41

e6/l

0.17

Disorders of continuity of bone

379

1.94

6.61

2.9

2.4

1452.14

1243.58

e6/l

0.40

332

Insulin, combination of fast acting with intermediate-acting or long-acting

395

2713

1.32

6.61

2.2

2.5

1108.89

1160.77

e6/l

0.58

347

2377

Malignant neoplasm of prostate

108

364

1.76

6.59

2.6

2.1

1020.35

1049.91

e6/l

0.09

330

Congenital malformations and deformations of the musculoskeletal system, including avohilmo

106

615

1.73

6.58

2.3

2.8

1459.27

1374.00

e6/l

0.44

491

Injuries to the thorax

292

2117

1.38

6.57

2.3

2.4

1263.23

1131.22

e6/l

1.76

247

1875

Diseases of peritoneum

353

1.97

6.53

2.3

2.2

1231.77

1136.33

e6/l

0.25

312

Vitreous haemorrhage

367

1.95

6.52

2.4

1134.65

1127.88

e6/l

0.03

332

Unspecific neurodegenerative disorder

1118

0.58

6.49

2.3

1.9

1094.89

1144.84

e6/l

0.15

1015

Polycystic ovarian syndrome, consortium definition

443

1943

1.31

6.46

2.5

2.2

1326.75

1298.01

e6/l

0.18

394

1675

Tongue abnormality

202

2.30

6.45

1.8

2.1

1066.82

1207.59

e6/l

0.57

179

Hepatic failure, not elsewhere classified

107

2.84

6.44

1.7

2.2

1046.70

1236.26

e6/l

0.53

Inflammatory disease of uterus

564

1.75

6.40

1.9

2.5

1465.31

1288.89

e6/l

1.37

476

Respiratory tuberculosis, confirmed and not-confirmed

136

2.60

6.37

1.6

1.9

1388.83

1100.08

e6/l

0.52

121

Respiratory tuberculosis

136

2.60

6.37

1.6

1.9

1388.83

1100.08

e6/l

0.52

121

Myopia

103

602

1.72

6.37

2.6

2.5

1342.61

1280.15

e6/l

0.29

504

Substance use, excluding alcohol

142

901

1.58

6.36

2.3

2.5

1487.27

1231.54

e6/l

2.56

124

781

Artificial opening status

185

2.35

6.33

2.1

2.2

1180.50

1189.18

e6/l

0.02

153

Scoliosis

337

1.97

6.30

2.1

2.7

1284.05

1174.13

e6/l

0.42

292

Spirochaetal infections, other/unspecified

344

1.96

6.30

1.9

2.2

1149.10

1196.66

e6/l

0.21

306

Bacterial, viral and other infectious agents, including avohilmo

365

1.93

6.29

2.4

2.8

1272.17

1293.36

e6/l

0.07

324

Nasal polyp

120

733

1.65

6.28

2.1

2.5

1368.31

1101.42

e6/l

2.85

660

Infective dermatitis

393

1.90

6.28

2.4

2.5

995.48

1116.62

e6/l

0.84

348

Trigeminal neuralgia

186

2.33

6.25

2.7

2.3

1374.47

1166.24

e6/l

0.91

165

Anogenital herpesviral [herpes simplex] infection

251

2.13

6.21

2.4

2.5

1257.68

1285.07

e6/l

0.11

213

Other arthrosis

305

1494

1.37

6.20

1.9

2.5

1238.77

1143.09

e6/l

0.97

271

1329

Mucosal proctocolitis

533

1.76

6.18

2.3

2.4

1185.75

1214.39

e6/l

0.10

458

Cluster headache, strict, including avohilmo

181

2.35

6.17

1.6

2.4

1472.12

1333.29

e6/l

0.44

161

Erosion of teeth , including avohilmo

197

1350

1.47

6.16

2.7

2.5

1270.46

1254.47

e6/l

0.08

160

1150

Fall on same level

797

3496

1.22

6.16

2.2

2.5

1255.20

1238.83

e6/l

0.15

685

3033

COPD, hospital admissions 1, only main diagnosis

189

1100

1.48

6.13

1.8

2.2

1226.35

1089.25

e6/l

1.42

169

992

Other or ill-defined heart diseases

163

2.41

6.12

2.3

2.7

1082.00

1309.94

e6/l

0.72

140

Congenital malformations of great arteries

192

2.32

6.10

2.2

3.9

1082.03

1569.58

e6/l

2.71

134

Transport accidents

320

1978

1.35

6.09

2.2

2.5

1319.23

1168.52

e6/l

2.37

271

1728

Other diseases of biliary tract

293

2.03

6.09

1.9

2.3

1015.64

1135.81

e6/l

0.45

259

Alzheimer disease

814

0.52

6.09

2.4

1.8

895.15

1051.10

e6/l

1.15

743

Degenerative diseases of the nervous system

966

0.56

6.02

2.3

1.9

931.88

1062.26

e6/l

1.09

876

Other crystal arthropathies

3.93

6.01

1.2

2.0

1207.71

905.13

e6/l

0.82

Infectious mononucleosis, including avohilmo

343

1.94

6.00

2.7

2.6

1204.45

1278.42

e6/l

0.32

281

Infectious mononucleosis

343

1.94

6.00

2.7

2.6

1204.45

1278.42

e6/l

0.32

281

Insulin, fast-acting

242

1730

1.40

5.99

2.0

2.6

1135.14

1206.59

e6/l

0.64

209

1502

Cluster headache, wide,, including avohilmo

190

2.29

5.98

1.6

2.4

1493.77

1312.39

e6/l

0.65

169

Degenerative macular diseases

386

1.88

5.96

2.0

968.60

1129.13

e6/l

1.06

344

Arthrosis

411

1724

1.31

5.93

2.2

2.5

1255.74

1164.79

e6/l

1.17

363

1522

Seborrhoeic keratosis

148

964

1.54

5.93

2.3

1186.90

1129.73

e6/l

0.30

136

864

Lichen planus

459

1.80

5.92

2.0

2.4

1164.73

1157.64

e6/l

0.02

409

Vitamin D deficiency

3.45

5.89

3.7

3.3

1331.00

1235.11

e6/l

0.10

Pure hypercholesterolaemia

440

2168

1.29

5.89

2.1

2.5

1271.87

1124.64

e6/l

2.25

380

1937

Hyperplasia of prostate

216

841

1.45

5.88

2.5

1132.06

1040.56

e6/l

0.69

195

762

Benign neoplasm of eye and adnexa

388

1.87

5.88

2.3

2.2

1283.21

1165.50

e6/l

0.26

348

Paracetamol or NSAID medication

110

326

1.71

5.87

3.5

3.2

1310.03

1129.95

e6/l

1.10

272

Cholecystectomy

430

2844

1.29

5.85

2.2

2.3

1215.12

1193.20

e6/l

0.16

380

2516

Other hammer toe(s) (acquired)

478

1.74

5.80

2.1

2.3

1209.39

1140.89

e6/l

0.17

430

Bacterial, viral and other infectious agents

334

1.93

5.77

2.5

2.9

1277.13

1270.17

e6/l

0.02

300

Other strabismus

164

1095

1.50

5.76

3.1

2.7

1252.86

1287.68

e6/l

0.23

142

912

Personal history of medical treatment

5.32

5.76

1.6

2.1

1227.88

1335.04

e6/l

0.18

Other and unspecified coagulation defects

175

2.31

5.70

2.4

2.6

1122.88

1317.22

e6/l

0.66

156

Speech disturbances, not elsewhere classified

280

2.01

5.70

2.3

2.2

1149.63

1166.43

e6/l

0.06

250

Postviral fatigue syndrome

4.91

5.69

1.1

2.1

1432.36

1437.69

e6/l

0.01

Hallux valgus (acquired)

184

896

1.47

5.67

2.1

2.4

1103.70

1186.04

e6/l

0.63

166

797

Cervical disc disorders

214

1515

1.42

5.65

2.1

2.4

1409.35

1101.70

e6/l

3.21

184

1358

Pain in thoracic spine

101

608

1.67

5.65

2.1

2.4

1288.15

1155.88

e6/l

0.74

541

Hypoplasia of dental enamel, prenatal , including avohilmo

3.30

5.60

5.5

4.4

1311.12

1741.37

e6/l

0.74

Other specified/unspecified bacterial intestinal infections

215

2.16

5.60

2.6

2.3

1376.61

1172.71

e6/l

0.57

193

Excessive, frequent and irregular menstruation

239

906

1.41

5.60

2.8

2.1

1303.88

1243.70

e6/l

0.57

209

783

Diseases of external ear

237

1711

1.39

5.59

2.4

2.5

1296.83

1192.43

e6/l

1.04

207

1492

Insulin, fast-acting or short human

244

1769

1.38

5.59

2.0

2.6

1137.37

1204.32

e6/l

0.59

211

1530

Internal derangement of knee

220

1552

1.41

5.58

2.3

2.5

1308.91

1155.78

e6/l

1.54

198

1364

Intestinal adhesions without obstruction

262

2.04

5.57

2.2

2.3

1114.40

1095.23

e6/l

0.06

235

malignant neoplasm of female genital organs

310

1.93

5.54

2.0

2.1

1086.32

1201.15

e6/l

0.58

268

Ovarian dysfunction

304

1.96

5.54

2.7

2.8

1436.57

1347.12

e6/l

0.32

259

Carcinoma in situ of skin

256

2.05

5.53

2.3

2.1

1034.00

1065.13

e6/l

0.11

232

Otitis externa

159

1070

1.49

5.51

2.5

2.6

1345.50

1212.04

e6/l

1.13

140

922

Insulin medication

395

2547

1.29

5.49

2.2

2.6

1108.89

1166.86

e6/l

0.67

347

2234

Cluster headache, strict

117

2.59

5.48

1.5

2.6

1450.23

1215.78

e6/l

0.61

106

Use of eye-antiallergens (taken as indicator of allergic/atopic conjunctivitis)

353

2596

1.30

5.48

2.3

2.4

1294.54

1235.57

e6/l

0.62

295

2244

Malignant melanoma of skin, including Hilmo

291

1.97

5.47

2.6

1.9

1063.27

1135.45

e6/l

0.36

259

Cerebrovascular diseases

441

2403

1.27

5.47

2.3

2.4

1352.26

1128.30

e6/l

0.50

391

2142

Chondropathies

105

645

1.64

5.45

3.3

2.5

1428.55

1225.34

e6/l

1.68

556

Disorders of lipoprotein metabolism and other lipidaemias

486

2345

1.26

5.43

2.1

2.5

1239.15

1129.43

e6/l

1.72

426

2089

Leisure time condition

122

778

1.58

5.42

1.9

2.4

2153.81

1186.55

e6/l

0.64

109

664

Selective serotonin reuptake inhibitors

639

2711

1.23

5.40

2.5

2.4

1269.34

1178.16

e6/l

1.08

544

2395

Other inflammation of eyelid, including avohilmo

295

2219

1.33

5.36

2.7

2.3

1258.30

1230.77

e6/l

0.26

261

1889

Benign neoplasm: Colon, unspecified

147

980

1.51

5.34

2.4

2.3

1038.99

1111.64

e6/l

0.42

131

883

Crowding of teeth, including avohilmo

433

1.72

5.33

2.8

3.1

1364.00

1386.50

e6/l

0.07

338

Exclusions for E4_PCOS_CONSORTIUM

473

2343

1.26

5.33

2.4

2.5

1295.31

1304.61

e6/l

0.06

404

2014

Injuries to the head

756

3736

1.20

5.31

2.4

1270.23

1219.28

e6/l

0.56

662

3244

Benign paroxysmal vertigo

175

1211

1.45

5.27

2.2

2.3

1203.66

1161.21

e6/l

0.33

160

1066

Ovarian cyst

212

855

1.42

5.27

2.2

2.1

1363.34

1232.42

e6/l

1.42

179

743

Cirrhosis, broad definition used in the article https://doi.org/10.1101/594523

582

1.66

5.26

1.7

2.4

847.95

1130.46

e6/l

3.60

520

Corneal ulcer

121

776

1.57

5.26

2.6

2.4

1230.16

1183.38

e6/l

0.23

108

665

Cardiomyopathy, other and unspecified

241

2.05

5.25

2.5

946.16

1199.45

e6/l

1.58

212

Vitamin B12 deficiency anaemia

303

1.93

5.24

2.3

2.2

980.16

1061.14

e6/l

0.42

270

Chronic periodontitis, including avohilmo

629

3293

1.22

5.23

2.5

2.3

1242.06

1195.72

e6/l

0.46

560

2895

Left ventricular outflow tract obstruction (LVOTO), broad definition

448

1.75

5.22

2.5

3.0

973.81

1247.57

e6/l

2.24

382

Cluster headache, wide

126

2.49

5.22

1.5

2.5

1484.13

1207.32

e6/l

0.79

113

Disorders of puberty, all

103

2.68

5.20

2.8

4.0

1207.57

1417.53

e6/l

0.63

Cirrhosis of liver, NAS

189

2.19

5.20

1.8

2.2

708.75

1202.49

e6/l

4.91

167

Adjustment and management of implanted device

523

1.69

5.19

1.6

2.4

940.35

1086.06

e6/l

1.19

458

Exposure to other specified factors

550

3842

1.23

5.19

2.4

2.5

1315.96

1192.70

e6/l

2.06

469

3346

Degeneration of macula and posterior pole

260

1481

1.36

5.18

2.1

2.3

1071.72

1165.53

e6/l

0.57

237

1336

Dystonia

196

2.16

5.17

2.8

2.3

1304.06

1231.27

e6/l

0.26

171

Hydrocele

405

1.79

5.16

2.4

2.6

1108.92

1038.02

e6/l

0.33

356

Congenital iodine-deficiency syndrome/hypothyroidism

2.83

5.16

1.6

2.1

1434.05

1084.23

e6/l

0.54

Elevated blood glucose level

319

1.90

5.16

2.3

2.7

1221.33

1187.39

e6/l

0.09

277

Injuries to the wrist and hand

688

3784

1.21

5.16

2.2

2.5

1245.76

1218.68

e6/l

0.28

601

3294

Injuries to the ankle and foot

497

3421

1.24

5.13

2.3

2.5

1286.49

1217.08

e6/l

0.80

420

2966

Decubitus ulcer and pressure area

177

2.22

5.13

2.1

2.0

1005.21

1052.99

e6/l

0.15

154

Embedded teeth, including avohilmo

392

1.80

5.11

2.2

2.7

1517.45

1345.93

e6/l

0.84

327

Hyperfunction of pituitary gland

171

2.24

5.11

2.8

2.7

1264.47

1266.94

e6/l

0.01

148

Vitiligo

3.64

5.09

3.1

2.0

1198.45

1326.00

e6/l

0.16

Congenital malformations of the circulatory system

117

729

1.57

5.08

3.1

2.9

1100.41

1335.48

e6/l

2.28

599

Obsessive-compulsive disorder

258

1.99

5.07

2.4

2.7

1319.02

1291.72

e6/l

0.08

220

Idiopathic gout

314

1.89

5.06

2.4

2.3

1044.94

1061.73

e6/l

0.05

285

Ulcerative rectosigmoiditis

293

1.93

5.06

2.1

2.8

1479.16

1202.44

e6/l

1.07

264

Other superficial mycoses

2.94

5.06

2.3

2.6

1225.00

1261.12

e6/l

0.05

Congenital malformations of heart and great arteries

110

676

1.59

5.05

2.4

3.1

1057.83

1317.62

e6/l

2.93

555

Nonspecific lymphadenitis

225

2.06

5.03

3.3

2.8

1458.83

1261.39

e6/l

0.62

197

Injuries to the hip and thigh

289

1959

1.33

5.02

2.5

2.3

1203.06

1151.01

e6/l

0.47

251

1734

Nonischemic cardiomyopathy

372

1.81

5.02

2.8

2.4

888.47

1144.62

e6/l

2.27

333

Periodontitis

628

3300

1.21

5.00

2.5

2.3

1245.83

1195.63

e6/l

0.51

559

2900

Other sleep disorders

439

1.74

5.00

2.1

2.5

1443.65

1125.90

e6/l

1.41

379

Specific developmental disorder of motor function

144

2.37

4.99

3.6

3.2

1701.77

1502.55

e6/l

0.33

Heartburn

373

1.81

4.99

2.4

2.5

1348.36

1170.54

e6/l

1.08

327

Peritonsillar abscess

129

850

1.52

4.98

2.3

2.7

1310.07

1172.10

e6/l

1.29

112

723

Oesophagitis

173

2.22

4.98

1.8

2.3

927.38

1135.49

e6/l

1.14

153

Ulcerative colitis (strict definition, all Crohn cases excluded)

101

630

1.61

4.97

2.1

2.4

1213.88

1206.80

e6/l

0.03

543

Coxibs

173

623

1.46

4.90

2.5

1284.61

1074.01

e6/l

2.24

150

542

Benign neoplasm: Stomach

325

1.86

4.89

1.9

2.0

1145.98

1090.79

e6/l

0.21

287

Benign neoplasm: Small intestine

118

2.49

4.89

2.1

1.7

1049.65

1176.78

e6/l

0.32

104

Caries of enamel

645

3499

1.21

4.88

2.7

2.4

1285.99

1224.23

e6/l

0.69

526

3096

Infarction of spleen

6.73

4.83

2.5

1.2

1659.18

1229.75

e6/l

0.44

Other and unspecified disorders of vitreous body

243

1766

1.35

4.82

2.3

1218.95

1153.06

e6/l

0.41

216

1587

Personal history of other diseases and conditions

525

1.66

4.80

3.5

2.3

1447.97

1381.90

e6/l

0.26

422

Presence of cardiac and vascular implants and grafts

222

1190

1.37

4.79

1.7

2.1

973.44

1162.47

e6/l

1.28

196

1070

Other behavioural and emotional disorders with onset usually occurring in childhood and adolescence

350

1.81

4.75

4.7

3.1

1540.16

1427.06

e6/l

0.32

268

Benign neoplasm: Other and unspecified parts of mouth

2.64

4.74

1.2

2.1

1217.47

1238.85

e6/l

0.04

Necrosis of pulp, including avohilmo

382

2990

1.26

4.73

2.3

2.4

1182.67

1208.98

e6/l

0.28

343

2618

Unspecified behavioural syndromes associated with physiological disturbances and physical factors +Physiological and behavioural factors associated with disorders of diseases classified elsewhere

2.77

4.72

7.2

3.5

1444.17

1349.70

e6/l

0.23

Other and unspecified bullous disorders

4.41

4.67

1.2

1.9

1223.89

1204.10

e6/l

—

Use of other anti-dementia drugs

712

0.53

4.63

2.3

1.8

910.88

1032.94

e6/l

0.57

652

Use of memantine

712

0.53

4.63

2.3

1.8

910.88

1032.94

e6/l

0.57

652

Other symptoms and signs involving the urinary system

390

1.75

4.62

2.7

2.5

1304.56

1126.85

e6/l

1.02

347

Speech therapy

155

1079

1.44

4.59

2.3

2.4

1166.57

1171.55

e6/l

0.03

127

957

Hypothyroidism, strict autoimmune, 3 medication purchases required

513

2815

1.23

4.58

2.2

2.3

1182.23

1234.77

e6/l

0.50

450

2455

Car occupant injured in other and unspecified transport accidents

125

835

1.50

4.57

1.8

2.6

1435.53

1244.59

e6/l

1.30

101

712

Amputation

326

1.82

4.53

1.5

1.9

1018.04

1107.81

e6/l

0.39

292

Phobic anxiety disorders

589

1.60

4.53

2.5

2.7

1453.75

1280.40

e6/l

1.28

492

Hypermetropia

363

1.78

4.52

3.3

2.6

1466.65

1339.14

e6/l

0.34

289

Intermittent heterotropia

312

1.84

4.52

2.9

2.8

1198.63

1388.26

e6/l

1.03

241

Cervicobrachial syndrome

130

878

1.49

4.51

1.9

2.4

1385.09

1172.90

e6/l

1.06

107

788

Presence of other devices

126

832

1.49

4.49

2.3

2.1

1269.58

1099.89

e6/l

0.95

118

746

Eustachian salpingitis and obstruction

364

1.77

4.49

2.8

2.7

1343.22

1308.46

e6/l

0.10

312

Other erythematous conditions

117

2.42

4.49

2.5

1052.74

1299.17

e6/l

0.81

104

Viral agents as the cause of diseases classified to other chapters, including avohilmo

2.56

4.49

3.2

2.3

1475.00

1436.90

e6/l

0.06

Mental retardation, excluding more controls

181

2.10

4.47

4.0

2.8

1200.25

1310.38

e6/l

0.30

134

Ventral hernia

139

954

1.46

4.45

2.3

2.4

2008.57

1159.87

e6/l

0.61

120

850

Allergic conjunctivitis

373

2859

1.26

4.41

2.3

2.5

1299.49

1238.24

e6/l

0.68

309

2475

Coxarthrosis

261

1272

1.33

4.41

2.2

2.4

1130.54

1131.97

e6/l

0.01

235

1147

Hidradenitis suppurativa

137

2.29

4.39

1.2

2.6

1492.77

1285.29

e6/l

0.48

123

Melanocytic naevi of trunk

510

1.64

4.39

2.0

2.4

1217.81

1238.39

e6/l

0.07

435

Fracture of rib(s), sternum and thoracic spine

179

1290

1.39

4.38

2.2

2.4

1248.00

1133.92

e6/l

0.93

152

1159

Abnormal findings on examination of other body fluids, substances and tissues, without diagnosis

363

2234

1.26

4.38

2.6

2.3

1239.11

1234.48

e6/l

0.03

327

1947

Disorders of speech understanding and production

240

1.94

4.36

2.8

3.5

1597.56

1441.18

e6/l

0.36

173

Alzheimer’s disease (Atypical or mixed)

274

0.29

4.35

1.4

1.8

616.50

1038.81

e6/l

—

248

Sulfonylureas

1010

0.62

4.35

1.8

2.1

921.16

1034.44

e6/l

0.74

919

Pleural plaque

266

1.89

4.35

2.1

2.0

1054.30

1067.79

e6/l

0.04

239

Other disorders starting during childhood or adolescence

357

1.77

4.34

4.6

3.2

1548.96

1469.23

e6/l

0.21

264

Alzheimer’s disease, strict definition

657

0.53

4.34

2.3

1.8

990.08

1028.08

e6/l

0.14

602

Fracture of foot, except ankle

167

1192

1.41

4.33

2.4

2.6

1269.67

1241.94

e6/l

0.15

137

1018

Malignant melanoma of skin

238

1.94

4.33

2.8

2.0

959.24

1112.77

e6/l

0.89

211

Restless leg syndrome

579

1.58

4.19

2.5

2.3

1283.55

1176.88

e6/l

0.64

509

Diseases of male genital organs

329

1294

1.28

4.19

2.7

1171.95

1132.82

e6/l

0.32

292

1115

Other shoulder lesions

365

1.74

4.17

2.5

1192.54

1122.52

e6/l

0.28

314

Other and unspecified erythematous conditions

109

2.41

4.16

2.5

2.6

1100.62

1316.20

e6/l

0.63

Oxicams

136

526

1.47

4.15

2.2

2.4

1272.64

1067.39

e6/l

1.51

121

463

KRA_PSY_EATING, excluding more controls

311

1.79

4.13

2.0

2.4

1549.95

1272.55

e6/l

1.54

254

conjunctival haemorrhage

271

1.86

4.13

2.2

1245.44

1125.17

e6/l

0.41

239

Viral hepatitis

286

1.83

4.11

3.1

2.6

1386.84

1259.67

e6/l

0.37

259

≡ Risteys

R14

FinnGen R13 + FinRegistry

FinnGen R12 + FinRegistry

FinnGen R11 + FinRegistry

FinnGen R10 + FinRegistry

FinnGen R10

FinnGen R9

FinnGen R8

FinnGen R7

FinnGen R6

FinnGen R5

FinnGen R4

FinnGen R3

CD3 cells [#/volume] in Blood

Coding

Definition

OMOP mapping QC

Cohort

Year of birth distribution

Age at first measurement

Age at last measurement

Age at start of registry

Duration from first to last measurement

Statistics

Number of measurements over the years

Number of measurements per person

Distribution of lab values

Value range per person

LabWAS